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Chapter 1
Headache in general is a common problem and accounts for up to 4.5% of the visits to the emer-
gency department [1]. For the treating physician the challenge lies in differentiating patients 
with primary headaches, such as migraine, tension type headache, or cluster headache, from 
patients with possible life threatening secondary headache. The causes of secondary headaches 
can be divided into three main groups: vascular causes, infectious and trauma. A suspicion of 
secondary headache may arise in patients who present with first ever headache, in acute or 
worst ever headache, in the presence of neurological deficit on examination or in patients with 
fever, systemic illness, pregnancy or immune deficiency.
Acute headache is defined as a severe headache that peaks within five minutes [2]. A subarachnoid 
hemorrhage (SAH) is the cause of isolated acute headache in approximately 11-25% of patients 
[3,4]. This is a diagnosis should not be missed as SAH has a high mortality and morbidity [4-7]. 
Other secondary headaches of vascular origin may be suspected in acute headache. Reversible 
cerebral vasoconstriction syndrome (RCVS) may be a cause of ‘benign’ thunderclap headache in 
which non-contrast head CT and LP are normal. It has been reported to be present in one out of 
eleven (8.8%) of patients with acute headache in whom signs of SAH are absent [8]. While some 
cases occur spontaneously or in the post-partum period, the majority of cases (60%) is caused 
by vaso-active substances (nasal decongestants, cannabis or XTC). It may have a benign course, 
but also ultimately cause SAH, cerebral hemorrhage or ischemia. Diagnosis can be made with 
angiography or MR angiography but imaging needs to be repeated over time [9]. Sometimes 
headache is the only symptom of vascular disease. Cervical artery dissection (CAD) may present 
with acute headache alone in 8% of cases[10,11], cerebral venous thrombosis (CVT) present with 
isolated headache in one in seven patients (14%) [12,13]. Cerebral ischemia may present with 
isolated headache in 2 to 25% of patient cases [14].
These causes of headache may still be present when neurological examination is normal. Herein 
lies a challenge: selecting the patients who benefit from CT angiography (CTA). In the current 
medical practice there is more focus on diagnostic sensitivity than specificity and the danger 
of too many diagnostic procedures is increasingly present, fuelled by the fear of missing an 
important diagnosis.
Another challenge is the selection of the correct imaging modality. In patients with a clear 
neurological deficit or altered consciousness after headache, either acute or not, it is clear that 
at least a non-contrast head CT or MRI should be performed. The imaging of the cervical and 
intracranial arteries with CT angiography (CTA) or MR angiography (MRA) may give additional 
information on the presence of RCVS, dissection or CVT. However, the choice for either CTA or 
MRI/MRA is also determined by the availability of each imaging modality and cost and duration 
of the scan. In the emergency department setting the high pressure on resources and time 
make MRI/MRA a less attractive imaging option. However the diagnostic yield of CTA may be 
insufficient. Furthermore, a CTA causes added radiation exposure and iodine contrast may 
cause allergic reactions and nephropathy. 
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What could be the consequence of a missed diagnosis in patients with acute headache? A pooled 
analysis of follow up studies with normal neurological examination and normal CT found no SAH 
after six months to one year follow up [15]. The authors advocated that no additional imaging 
is necessary. Unfortunately follow up time was relatively short and not all patients received 
additional CTA or MRI. The authors suggest that the natural course in these patients is benign 
even if other diagnoses such as RCVS, dissections, CVT or meningitis are missed. 
Patients presenting to the emergency room may have a wide range of secondary headaches 
or non-threatening, albeit painful, primary headache. In this thesis a variety of diagnostic tests 
and their diagnostic yield are evaluated in patients with both vascular and infectious secondary 
headache. In each case the question is addressed whether expansion or reduction of diagnostic 
testing is necessary. Apart from identifying patients who benefit from cranial imaging we also 
searched for methods to avoid unnecessary scanning. We evaluated the yield of CTA in patients 
with acute headache in a retrospective study and a meta-analysis in chapter 2 and 3. Secondly 
we evaluated possible clinical criteria for a more purposeful selection of headache patients for 
CTA in chapter 4.
In the past few years lumbar puncture after acute headache is performed less frequently. The 
turning point has been the publication of an article which showed that when a CT is made within 
6 hours after the start of the acute headache a lumbar puncture is no longer necessary to rule 
out SAH due to high sensitivity of current CT techniques [16]. If CT is performed more than six 
hours after acute headache a lumbar puncture is still mandatory to exclude hemorrhage. If other 
diagnoses necessitating cerebrospinal fluid testing are suspected a lumbar puncture is of course 
also needed. Also, if on imaging an aneurysm is detected a lumbar puncture is still necessary to 
evaluate whether this aneurysm has bled or whether it is an unruptured intracranial aneurysm 
(UIA) and a coincidental finding. The lumbar puncture is needed to evaluate intrathecal bilirubin, 
a blood breakdown product. Visual inspection lacks sensitivity and photospectometry is used 
to determine bilirubin based on an absorbance of 450-460 nm. We compared two methods of 
photospectometry evaluation in order to evaluate sensitivity and specificity in chapter 5. 
To further investigate the value of cerebrospinal fluid (CSF) analysis we also performed a 
prospective study concerning the determination of procalcitonin in CSF in the diagnosis of 
bacterial meningitis. Viral or bacterial meningitis may present with headache alone and may be 
difficult to differentiate based on classic CSF findings [17]. Patients with an external ventricular 
drain after SAH have an increased risk of contracting bacterial meningitis due to a foreign body. 
Clinical signs and symptoms may be unclear as patients with SAH also may have nuchal rigidity 
and lowered consciousness. A diagnostic marker to differentiate between bacterial infection and 
aseptic meningitis would be valuable. 
Procalcitonin is an acute phase protein and may become such a marker. There is evidence 
sug gesting it is produced intrathecally by glia cells [18]. In serum it is produced in response to 
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Chapter 1
bacterial infection. We studied procalcitonin formation in a varied group of patients suspected 
of viral or bacterial meningitis in chapter 6.
In patients with acute or worst ever headache cerebral venous thrombosis is often considered. 
Patients with a normal neurological examination may have CVT and are at risk for secondary 
deterioration [19]. In patients suspected of pulmonary embolism or deep venous thrombosis 
Wells criteria are employed in combination with D-dimer to determine which patients are at low 
risk. Patients in the low risk category do not require further imaging. In chapter 7 we performed 
a meta-analysis to determine whether D-dimer may play a similar role in the work up of patients 
with suspected CVT and a normal neurological examination and normal non-contrast head CT.
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Patients with acute severe headache may have a secondary form of headache. Standard head 
computer tomography (CT) and cerebrospinal fluid (CSF) examination are often performed 
in absence of neurological deficits to exclude subarachnoid hemorrhage (SAH). Increasingly 
patients undergo subsequent CT angiography (CTA) to exclude cerebral venous thrombosis (CVT), 
dissection or reversible cerebral vasoconstriction syndrome (RCVS). It is unknown whether this 
additional imaging increases diagnostic yield. We aimed to evaluate the yield of CTA in patients 
with acute severe headache with normal neurological examination and no abnormalities at 
standard CT and CSF analysis. 
Methods 
We included consecutive patients presenting to the emergency room between January 2008 and 
May 2011 with acute severe headache and without abnormalities at neurological examination, 
CT and CSF research, who received a CTA in the diagnostic process in our teaching hospital. All 
scans were re-reviewed by an experienced neuroradiologist.
Results 
We included 70 patients, 71% were women and average age was 45 years. We found a vascular 
abnormality in 13 (19%) of our patients. Four had either a prior aneurysm or CVT. Eight patients 
had an unruptured intracranial aneurysm (UIA) on CTA (11%), 2 had CVT (3%), 2 had RCVS (3%) 
and 1 had cerebral ischemia (1%). 
Conclusions 
We found a high percentage of vascular abnormalities. A third of these patients had a prior 
episode of either an aneurysm or CVT. In patients with a history of UIA or CVT performing 
CTA despite normal CT and LP therefore seems warranted. A prospective study to delineate 
indications for CTA is needed.
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BACKGROUND
Acute severe headache is defined as a headache of extreme severity that reaches its maximum 
within minutes and lasts for >1 hour. Acute severe headache may be a presenting symptom of, 
among others, a subarachnoid hemorrhage (SAH), cerebral venous thrombosis (CVT), arterial 
dissection, cerebral ischemia or reversible cerebral vasoconstriction syndrome (RCVS). Many 
studies have been published with regard to the correct sequence and content of diagnostic 
procedures. When standard CT is performed within six hours of the start of the headache 
SAH can be excluded, if performed in a center specialized in SAH. If CT is performed later, or 
if headache is atypical a lumbar puncture (LP) is still indicated [1,2]. However, in following this 
approach several diagnoses with severe consequences, other than SAH, may be missed. For 
example CVT may present with acute severe headache, without neurological deficit in 3-13% 
of cases [3,4]. Cervical arterial dissection has been reported to present with acute headache 
as the only symptom in 20% of cases [5,6]. Also, unruptured aneurysms are being reported as 
a possible cause of acute headache in several case reports [7-9]. RCVS has been reported to 
present with isolated headache in 57% to 88% of the cases [10].
CTA is increasingly used in patients with acute severe headache to rule out vascular abnormali-
ties and has been proven valuable in detecting aneurysms [11]. To our knowledge there are no 
prospective studies investigating the gain of CTA in patients with acute severe headache, normal 
neurological exam and normal standard CT. One retrospective study that reviewed CTA in this 
group, found a higher percentage of vascular abnormalities (6.6%) than expected in the general 
population. However, lumbar punctures were not performed in that cohort. Also their study 
population was entirely Asian making extrapolation to our population difficult [12]. 
The risks of performing standard CTA include nephrotoxicity, added radiation exposure and 
allergic reactions. Furthermore, diagnostic procedures such as CTA increase costs. It is unclear 
whether these negative effects outweigh possible prevention of morbidity with a more ag-
gressive screening approach. A study focusing on the added yield of CTA in patients with 
acute headache showed that CTA may be used selectively based on standard CT findings, thus 
increasing specificity and reducing patient risk [13]. We investigated the yield of CTA in patients 
with acute severe headache, without neurological deficit and a normal CT head and CSF for 
detecting vascular abnormalities.
PATIENTS AND METHODS
We performed a retrospective analysis researching the imaging findings of patients who pre-
sented at the emergency room in our large regional teaching hospital. These patients were 
previously described in a study focusing on cerebrospinal fluid (CSF) diagnostics [14]. For that 
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study we included patients from January 2008 through May 2011 with acute, non-traumatic, most 
severe ever, headache who underwent a lumbar puncture. For the present study we excluded 
patients with neurological deficits on examination, pathological findings on standard head CT, 
such as SAH or subdural hematoma, and patients with an increased bilirubin concentration (>0.2 
μmol/l) in CSF. All imaging modalities were evaluated by specialized neuroradiologists at the 
time of presentation. The conclusions of the scans that were made at that time were collected. 
For this study all scans of included patients were re-reviewed by an experienced neuro radio-
logist. In accordance to hospital protocol CSF research was performed at least 12 hours after the 
onset of symptoms in all patients with normal standard CT. Collected samples were transported 
to the in-house laboratory and protected continuously from light. We documented and evalu-
ated the outcome of performed CTA’s. The CTA depicts both the arterial and venous system 
of intra- and extracranial vessels, by scanning the early and late phase of contrast passage. All 
patients underwent scanning by GE Lightspeed 64 slice CT scanner. Where available we also 
evaluated MRI and MRA data. Patient data were processed and descriptive statistics were done 
using SPSS 20.
RESULTS
Between January 2008 and May 2011, 361 patients presenting with acute and worst ever head-
ache were seen in the emergency department. We included 70 patients who received a CTA and 
had normal neurological exam, normal CSF bilirubin and normal non-contrast CT’s (see figure 1 
for patient flow). All but one scan were made within a week of the occurrence of the headache; 
one scan was made after three weeks. All patients received CTA imaging of the head and the 
intra- and extracranial vessels down to the level of the fourth cervical vertebra and 31 patients 
were additionally scanned down to the aortic arch. Of our patients 50% received sufficient 
imaging of the cervical arteries to exclude dissection, including subsequent MRA.
The average age in this group was 45 years, ranging from 17 to 80 years old and 50 were women 
(71%). Nine patients had a prior history of migraines, eight had a history of tension type headache 
and the other 53 patients had no history of prior headaches. Of our patients 61 presented with 
generalized headache, in 19 there was unilateral headache. Nausea and vomiting were present 
in respectively 30 and 16 patients. Thirteen (19%) had a vascular abnormality, which had clinical 
consequences for ten patients (table 1). Eight had an aneurysm (11%, 95% CI: 4% to 19%). In 
three patients the aneurysm was coiled, in another three clipped and two patients received 
follow up CTA’s to monitor aneurysm size. Four patients had small aneurysms of 2 and 3 mm 
and four patients had larger aneurysms ranging from 7.5 to 12mm. Three patients had been 
treated on a previous occasion after an SAH, but now had a second episode of acute headache 
and a de novo aneurysm. These aneurysms had not been seen on previous imaging. During our 
current revision they were not visible on previous scans either and were truly deemed de novo 
aneurysms. Of these de novo aneurysms one was also clipped and two were coiled. All three 
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patients were included after the second headache episode. We found 2 patients with a CVT 
(3%) One patient with CVT had her diagnosis confirmed on MRA, as CTA findings were suspect. 
The other had a prior CVT and returned with a new episode of acute severe headache, nausea 
and vomiting. The CVT had progressed when compared to prior imaging. There were no other 
patients with a prior history of SAH or CVT, one patient had a prior, treated, AVM but now had 
normal CT, LP and CTA.
One patient had ischemia of the posterior circulation in the right occipital area. This patient 
presented with acute headache and non vertiginous dizziness. Ischemia was visible as this scan 
was performed two days later and had become demarcated.
Two patients had RCVS and were not diagnosed at initial presentation, but after reviewing the 
CTA’s for this study. These were the only new abnormalities found by re-reviewing the scans. 
One patient presented with a single headache episode. The other visited again with another 
headache episode two days later, but remained undiagnosed at that time. Both did not revisit 
the emergency room or outpatient clinic after these episodes.
Figure 1. Patient inclusion flowchart
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Of all 70 patients 15 patients underwent an additional MRI, four of whom had an aneurysm 
diagnosed with CTA and one of whom had CVT confirmed. In the remaining 10 patients who 
received MRI no pathology was found.
DISCUSSION
In this study we set out to evaluate the diagnostic yield of CTA in headache patients with a normal 
neurological examination, normal standard CT and normal lumbar puncture. With CTA we found 
a surprisingly high percentage of underlying vascular abnormalities (19%). Three patients had a 
prior SAH and one prior CVT. These findings had clinical consequences for ten patients.
In the general population the prevalence of aneurysms is estimated to be around 3.2% [15,16]. 
However, after correction for age and the percentage of women, the prevalence in our group 
should is calculated to be 3.6% [16]. Possibly this percentage is an underestimation as we have 
no data on family prevalence in our group and some patients had prior aneurysms. According to 
this prevalence we would have expected to find at least 3 aneurysms in our group of 70 patients. 
We found eight aneurysms (11%), with a 95% confidence interval from 4% to 19%. Half of the 
found aneurysms were small, but the other half were larger: up to 12mm. Whether the finding 
of an aneurysm caused the acute headache in our patients is debatable as lumbar punctures 
were normal. Nevertheless it has been suggested that unruptured aneurysms may cause 
headache due to inflammation or sudden distension. Three patients had a de novo aneurysm 
after treatment for prior aneurysmatic SAH. Two patients had CVT, one of whom had a prior CVT 
which had now progressed. Our study suggests that patients with prior SAH, and possibly CVT, 
should receive CTA despite normal CSF after a second episode of acute headache. In our group 
5 patients had a prior history of cerebral vascular abnormalities. The four patients mentioned 
above and a patient with a history of a treated AVM who now had a normal CTA. This would 
mean 80% of the patients in our group of 70 with a history of cerebral vascular disease and a 
recurrent thunderclap headache had a de novo cerebral abnormality.
We found two patients with RCVS. This may be explained as cortical subarachnoid hemorrhage 
can be found in these patients, and the presence of abnormalities on standard head CT was 
an exclusion criterion in our study. Also RCVS may be more accurately diagnosed by repeated 
neuro-imaging and possibly MRA [17]. We found no dissections, which may be due to the fact 
that only 50% of patients received sufficient imaging of the carotid and vertebral arteries to 
exclude this diagnosis.
Our study has several limitations. First due to the retrospective design of our study there may 
be an indication bias. The patients with prior aneurysms and CVT are logical candidates for 
follow up by CTA, possibly increasing the chance of finding vascular abnormalities. Second this 
study is single center so our findings may not be generalizable. Tertiary headache centers may 
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find higher yield by referral bias, whereas primary centers may find lower percentages. The 
assessment of all clinical symptoms, such as detailed headache characteristics, was beyond the 
scope of this study. 
One study with a similar design found 6.6% vascular lesions in 512 patients (33 aneurysms, 2 
Moya Moya syndromes and 1 dissection), also suggesting value in performing CTA in this patient 
group [12]. The lower percentage of vascular abnormalities in that group compared to our 
findings may be partially explained by their exclusion of patients with prior intracranial vascular 
pathology. If these patients are excluded from our data, we still find 9 (14%) patients with 
vascular abnormalities. An important discrepancy with our methods is that lumbar punctures 
were not performed in this group to exclude hemorrhage, moreover, all their patients were 
Asian limiting the extrapolation of that study to our population. 
Evidence from earlier studies suggests that patients with acute severe headache, without 
pathological findings on non-contrast CT and lumbar puncture do not require follow up, 
however, some if these studies did not perform CTA and focused mainly on SAH [18-22].
A prospective study performing CTA in patients with acute headache, normal neurological 
examination, normal head CT and normal lumbar puncture is needed, to investigate the yield 
of CTA and assess whether it is possible to make a selection for CTA for specific subgroups of 
patients based on clinical characteristics, thus reducing unnecessary exposure to radiation and 
intravenous contrast.
ETHICAL STANDARDS
As this was a retrospective study, without medical interventions, patient consent was not 
required according to hospital protocol and national guidelines.
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Patients with acute severe headache, normal neurological examination and a normal non-
contrast head CT (NCCT) may still have subarachnoid hemorrhage (SAH), cerebral venous throm-
bosis (CVT), cervical arterial dissection or reversible cerebral vasoconstriction syndrome (RCVS). 
CT-angiography (CTA) is used increasingly in the emergency department (ED) for evaluating this, 
but its added value remains controversial.
Methods 
We retrospectively collected data on the diagnostic yield of CTA in patients with acute severe 
headache, normal neurological examination and normal NCCT who received additional CTA in 
the acute phase in two secondary referral centers for vascular neurology. We combined data of 
our patients with those from the literature and performed a meta-analysis.
Results 
We included 88 patients from our hospital files and 641 patients after literature search. Of 729 
patients 54 had a vascular abnormality on CTA (7.4%; 95%CI 5.5-9.3%). Abnormalities consisted 
of aneurysms (n=42; 5.4%; 95%CI 3.8-7.0%), CVT (n=3, 0.5%), RCVS (n=4, 0.5%), Moya-Moya 
syndrome (n=2, 0.3%), arterial dissection (n=2, 0.3%) and ischemia (n=1, 0.1%). Because most 
of the aneurysms were probably incidental findings, only 12 (1.6%) patients had a clear relation 
between the headache and CTA findings. The number needed to scan to find an abnormality was 
14 overall, and 61 for an abnormality other than an aneurysm. 
Conclusion 
Diagnostic yield of CTA in patients with acute headache, normal neurological examination and 
normal NCCT is low, but because of the possible therapeutic consequences its use might be 
justified in the emergency setting. Prospective studies confirming these results including cost-
effectiveness analyses are needed.
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INTRODUCTION
Acute headache may be the only presenting symptom of life threatening secondary headache 
syndromes. Patients with acute severe headache and a normal neurological examination may 
have subarachnoid hemorrhage (SAH), but also cerebral venous thrombosis (CVT), cervical 
arterial dissection (CAD) or reversible cerebral vasoconstriction syndrome (RCVS).[1-8] 
Computer Tomographic Angiography (CTA) is increasingly used in the emergency setting for 
evaluating these important causes of secondary headache. CTA has been proven sensitive in 
determining the presence of aneurysms and CVT and to a lesser extent RCVS and dissections.
[9,10]   CTA has higher accessibility than MRI in most hospitals. Also cost and time reductions 
compared with MRI make it a possible valuable modality in evaluating ED patients, although CTA 
is more expensive than non-contrast head CT (NCCT) alone. There are other drawbacks of CTA. 
First, there is an added radiation exposure of approximately 2.5mSV after the NCCT which is 
also 2.5 mSV, with a total of 5 mSV.[11] Second, intra-venous (IV) iodinated contrast media may, 
rarely, cause allergic reactions and contrast nephropathy, particularly in patients with known 
nephropathy.[11,12] 
The diagnostic yield of CTA in patients with acute headache and normal neurological examination 
and non-contrast head CT is unclear. A pooled analysis of follow up studies in patients with acute 
severe headache reported that in the group with normal non-contrast CT and normal lumbar 
puncture none had subsequent SAH. Based on these findings the authors advocated that CTA 
should not be used on a standard basis in these patients.[13] However, the included studies 
had a limited follow up period and in most patients CTA was not performed. Two large series of 
patients with acute headache concluded that if a NCCT is normal when performed within 6 hours 
of the start of the headache, a lumbar puncture is no longer needed due to the highly sensitive 
nature of third generation CT scanners.[15,16] This strategy is applicable to the exclusion of SAH, 
but because CTA was not performed in most patients, other diagnoses such as CVT, RCVS or 
CAD might have been missed. Two studies report percentages of vascular abnormalities ranging 
from 6.6 to 19%, in patients with acute severe headache, normal neurological examination 
and normal NCCT.[17,18] This is higher than may be expected in the general population. The 
first study was a large prospective study of 512 patients, but it was unknown whether lumbar 
punctures had been performed in these patients. In this study a large number of aneurysms was 
found, but it was not clear whether these were ruptured or unruptured intracranial aneurysms 
(UIA).[17] The second study from our own group had a limited size and patients were selected 
based on a normal lumbar puncture. This may have caused selection bias.[18]
The aim of our study was to evaluate the yield of CTA in patients presenting with acute severe 
headache to the (ED) in whom neurological examination and head NCCT was normal using both 
our own patient population and a meta-analysis of the literature.
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We retrospectively evaluated data on all patients who underwent a cerebral CTA between 2011 
and 2014 in the ED of the Leiden University Medical Center (LUMC), a tertiary vascular neurology 
referral center and university teaching hospital, and the MC Haaglanden, a secondary vascular 
referral center and primary teaching hospital. We included all patients who presented with acute 
headache, defined as headache that developed within 5 minutes and lasted for at least 1 hour. 
In the Leiden University Hospital patients were scanned from the aortic arch up using the 
Aquilion One (Aquilion-ONE, Toshiba Medical Systems, Tokyo, Japan) and Aquilion 64 CT scanner 
(Aquilion 64, Toshiba Medical Systems, Otawara, Japan). In the MC Haaglanden patients were 
scanned from the aortic arch to the vertex with a GE Lightspeed 64-slice scanner.
We charted patient characteristics (age, sex, patient history and medication, seizures, loss of 
con sciousness before admission, nausea, vomiting) and headache characteristics (location, 
duration, mode of onset, presence of aura, autonomous symptoms). We recorded results of CTA 
and other diagnostic procedures including lumbar punctures, digital subtraction angiography 
(DSA) and MRI when performed. Patients with focal neurological deficits, abnormalities on stan - 
dard NCCT and, if performed, abnormal CSF findings (raised pressure and CSF chemistry showing 
hemorrhage or infection) were excluded. We recorded all adverse events that were possibly 
related to the CTA such as allergic reactions, kidney failure or infections after IV catheter use.
The study was approved by the local ethics committee and hospital board of both the LUMC and 
MC Haaglanden.
Literature search
The literature search was performed with Pubmed. Reference lists of relevant articles were 
scanned for further usable articles. Search terms were “acute headache”, “thunderclap 
headache”, “CT angiography”, “neuro-imaging”, “subarachnoid hemorrhage” and combinations 
thereof. We evaluated all articles published up to and including 2015.
Articles were included in the meta-analysis if they consisted of original articles including con-
secutive patients with acute, severe or worst ever headache who were evaluated by CTA. Case 
reports and case series were excluded to eliminate publication bias. Reviews and non-English 
articles were also excluded.
We charted CTA results and, when performed, results of MRI, LP and DSA. We also recorded 
adverse events possibly related to CTA. 
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All articles were read extensively and data were extracted with a data extraction form. If data 
were missing authors were contacted with the request for additional information.
RESULTS
Own Data 
In the LUMC and MC Haaglanden 391 patients with acute headache who received a CTA were 
identified. Of the 391 patients 88 had a normal neurological examination and a normal NCCT. In 
31 of the 88 patients a lumbar puncture was performed with normal results and 57 patients did 
not receive a lumbar puncture. A large number of patients had a history of migraine; 64 (73%). 
Eight patients had a history of SAH (9.5%). Four patients presented twice with acute headache. 
One presented twice within three months and was diagnosed with RCVS. The other three 
patients presented over a period of one year and were diagnosed with primary thunderclap 
headache. All other patients presented with first ever headache. Overall 5 patients (5.7%) had 
a vascular abnormality on CTA (Table 1, Patient characteristics). In 4 (4.5%) of these patients 
the abnormality was considered to be the cause of the headache, the other patient had a small 
unruptured aneurysm with a normal LP.
Literature
Through the Pubmed search a potential 1533 articles were identified . After elimination of 
duplicates, non-English articles, case reports, case series and reviews 482 articles remained. 
After scanning of titles and abstracts 12 potential articles were selected for further reading.[9, 
17-26] Six articles met the inclusion criteria,[17-22] but only 3 articles gave sufficient information 
in order to ascertain the presence of a combination of a normal neurological examination, 
normal standard head CT and, if performed, a lumbar puncture without signs of hemorrhage.
[17,18,20] Authors of the remaining three articles were contacted for additional information, 
however none of them responded.
A total of 641 patients were identified through literature search. Of these patients 49 had an 
abnormality on CTA (7.3%). (Table 2)
Combined data
We identified 729 patients with acute severe headache who met inclusion criteria. Average age 
was 46 years and there were 54.8% women. A CTA including the cervical arteries was performed 
in 182 patients. Fifty-four had an abnormality on CTA (7.4%; 95% CI 5.5-9.3%); table 3 provides 
an overview of abnormalities found. The patients with an abnormality on CTA had an average 
age of 50 years and 31 were women (57%). The abnormalities consisted of one patient with right 
occipital ischemia (0.1%), 2 cervical dissection (0.2%), two patients with abnormalities suspect 
for Moya-Moya syndrome (0.3%), three CVT (0.4%), four patients with RCVS (0.5%) and 42 cases 
with aneurysms (5.8%; 95% CI 4.1-7.5%). In nine out of 42 patients with an aneurysm a lumbar 
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Table 1. Patient characteristics own series
Characteristics Patients (n=88)
Age (mean ± SD) 45.9±14.9
Women 63 (72%)
Neurological history
   Migraine
   Tension Type headache







<6h presentation at ER
6-24h
>24h





Location headache   
   Whole head
   Half-sided 
   Localized






   Throbbing
   Stabbing
   Pressing
   Nagging
   Other







Adverse events CTA 1 (1%)
Abnormal CTA
   Aneurysm
   CVT
   RCVS







   normal dissection
   Ischemia





   normal




Legend: ER emergency room, CTA CT angiography, CVT cerebral venous thrombosis, RCVS reversible cerebral 
vasoconstriction syndrome
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Table 3. Characteristics of patients with an abnormality on CTA
Number Sex Age Study Abnormality Follow up
1 F 30 Han et al. Aneurysm, ICA 3.4mm Clinical FU
2 M 56 Han et al. Aneurysm, ICA 2.7mm Clinical FU
3 F 35 Han et al. Aneurysm, ICA, 4.2 mm Clinical FU
4 M 52 Han et al. Aneurysm, ICA, 3.5 mm Clinical FU
5 F 71 Han et al. Aneurysm, ICA, 9.4 mm Refused treatment
6 F 70 Han et al. Aneurysm, ICA, 3.3 mm Clip ligation
7 F 27 Han et al. Aneurysm, ICA, 3.8 mm Follow-up with CTA
8 F 50 Han et al. Aneurysm, ICA, 2.0 mm Clinical FU
9 M 56 Han et al. Aneurysm, ICA, 2.6 mm Follow-up with CTA
10 F 67 Han et. al. Aneurysm, ICA, 2.0 mm Clinical FU
11 F 40 Han et al. Aneurysm, ICA, 2.9 mm Clinical FU
12 F 42 Han et al. Aneurysm, ICA, 2.8 mm Clinical FU
13 M 47 Han et al. Aneurysm, AcomA, 3.0 mm Clip ligation
14 F 41 Han et al. Aneurysm, AcomA, 13.1 mm Coil insertion
15 M 37 Han et al. Aneurysm, AcomA, 3.5 mm Refused treatment
16 F 57 Han et al. Aneurysm, AcomA, 5.6 mm Clip ligation
17 F 68 Han et al. Aneurysm, AcomA, 2.5 mm Clinical FU
18 M 61 Han et al. Aneurysm, AcomA, 2.7 mm Clinical FU
19 M 48 Han et al. Aneurysm, AcomA, 4.6 mm Coil insertion
20 M 80 Han et al. Aneurysm, MCA, 6.9 mm Clip ligation
21 M 64 Han et al. Aneurysm, MCA, 2.5 mm Clinical FU
22 F 55 Han et al. Aneurysm, MCA, 2.1 mm Follow up with CTA
23 M 46 Han et al. Aneurysm, MCA, 2.0 mm Clinical FU
24 F 55 Han et al. Aneurysm, MCA, 2.1 mm Clinical FU
25 F 65 Han et al. Aneurysm, MCA, 3.0 mm/ACA, 2.5 
mm
Clinical FU
26 M 33 Han et al. Aneurysm, PcomA, 3.5 mm Coil insertion
27 F 23 Han et al. Aneurysm, PcomA, 4.0 mm Coil insertion
28 M 49 Han et al. Aneurysm, PcomA, 2.7 mm Follow up with CTA
29 F 51 Han et al. Aneurysm, PcomA, 3.0 mm Clinical FU
30 M 54 Han et al. Aneurysm, PcomA, 11.0 mm/MCA, 
3.0 mm
Coil insertion
31 F 53 Han et al. Aneurysm, BA, 3.3 mm Refused treatment
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Number Sex Age Study Abnormality Follow up
32 M 37 Han et al. Dissection, VA Medication change
33 F 50 Han et al. Moya Moya disease Follow up with MRA
34 M 32 Han et al. Moya Moya disease Follow up with MRA
35 F 31 Alons et al. Aneurysm, MCA, 2 mm Clip ligation*
36 F 67 Alons et al. Aneurysm, AcomA, 3 mm Follow up with CTA*
37 M 62 Alons et al. Aneurysm, MCA, 3 mm Clip ligation*
38 F 54 Alons et al. Aneurysm, MCA, 8 mm Coil insertion*
39 F 61 Alons et al. Aneurysm, AcomA, 7.5 mm Coil insertion*
40 F 58 Alons et al. Aneurysm, PcomA, 2 mm Follow up with CTA*
41 F 38 Alons et al. Aneurysm, ICA, 7.5 mm Coil insertion*
42 F 48 Alons et al. Aneurysm, Pcom, 12 mm Coil insertion*
43 M 37 Alons et al. CVT transverse and sagittal sinus Anti-coagulant therapy
44 F 53 Alons et al. Cortical vein thrombosis None
45 M 48 Alons et al. RCVS None
46 F 30 Alons et al. RCVS One recurrent episode
47 M 73 Alons et al. Ischaemia right occipital lobe Medication change
48 - - Rizk et al. UIA Follow up with imaging
49 - - Rizk et al. UIA Follow up with imaging
50 F 51 Current study Aneurysm, MCA,10 mm Clip ligation*
51 M 42 Current study RCVS Clinical follow up†
52 M 42 Current study RCVS Clinical follow up†
53 F 36 Current study CVT Medication Change
54 M 46 Current study Dissection left ICA Medication change
Legend: ICA internal carotid artery, Acom Anterior communal artery, MCA medial carotid artery, PcomA 
posterior communal artery, BA basilar artery, VA vertebral artery, CVT cerebral venous thrombosis, RCVS 
reversible cerebral vasoconstriction syndrome, UIA unruptured intracranial aneurysm. * lumbar puncture 
normal, † CT<6 hours after peak headache
Table 3. Continued 
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puncture was performed, which showed no signs of hemorrhage in none of these patients. Of 
the remaining 33 patients no data on whether an LP was performed or outcome of LP were 
found. Of the 42 patients with an aneurysm, 25 patients received either coiling or clipping of an 
aneurysm. 
Four patients received altered medical treatment concerning CVT or stroke. Of the remaining 
patients, 23 received either clinical or imaging follow up. The number needed to scan for finding 
an abnormality likely causative of the acute headache was 61. In 12 patients (1.6%) there was a 
clear relation with the acute headache. When one considers unruptured aneurysms to be clini-
cally relevant, the number needed to scan is 14 (n=54).
One patient in this series had an adverse event, an allergic reaction to contrast iodinated contrast 
media, with reversible effect and short term harmful effects for the patient.
DISCUSSION
In our meta-analysis an vascular abnormality was identified with CTA in 7.4% of patients with 
acute severe headache and a normal neurological examination and NCCT of the head. In 12 
(1.6%) patients this abnormality was presumably the cause of the headache. 
The number of aneurysms found is slightly higher than might be expected in the general 
population. This number is dependent on the percentage of women and the average age. For all 
patients described here the expected percentage would be 3.2%.[27] 
The question remains whether these aneurysms are of clinical significance. If an aneurysm has 
not actively bled it is probably not the cause of the acute headache, but an incidental finding. 
An LP is necessary to rule out hemorrhage. However, in a large proportion of patients with an 
aneurysm in this series the outcome of the LP was unknown and therefore we cannot determine 
if the aneurysm had ruptured or not.  Radiological follow-up may be offered to patients with an 
unruptured intracranial aneurysm, however, it is unknown if such a follow-up strategy is cost-
effective.  The necessity to treat an aneurysm depends on the estimated risk of rupture, which in 
turn depends on patient factors such as age, hypertension, location of the aneurysm, previous 
SAH and ethnicity of the patient. [28] As not all factors were known to us in this patient group, 
the necessity of treatment of the detected aneurysms could not be determined. A considerable 
number of patients with aneurysms in this series has been treated but because we were unaware 
of the indication of treatment we cannot confirm that they are clinically relevant.
We found a surprisingly low number of patients with RCVS. In a recent paper RCVS was found 
in 8.8% of the patients using MRI/MR angiography. It is likely that CTA is not the ideal modality 
for diagnosing this condition. Also it is postulated that RCVS may only be seen on imaging in 
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a later stage and repeated imaging improves sensitivity. [9] Cervical artery dissection is often 
suspected in patients with acute headache. In this series only 2 of the 182 patients who received 
CTA including the carotid and vertebral arteries had a cervical artery dissection (1.1%; 95% CI 
-0.4-2.6%). Our data suggest that it is a relatively rare cause of secondary headache, but since 
not all patients had a CTA from the aortic arch, this may be an underestimate.
In this patient group there was only one recorded adverse event; an allergic reaction to iodinated 
contrast media, with reversible effect and short term harmful effects for the patient. Possible 
adverse events after CTA are nephrotoxicity and allergic reactions to iodinated contrast media.
[12,13] It is likely that in this group of relatively young patients, with little comorbidity, renal 
function is good thus reducing the risk of nephrotoxicity. The chance of contrast nephropathy 
in patients receiving CTA after acute stroke is low and reported to be 2-3.2% including only 
mild, reversible nephropathy.[12,13] Underreporting may have also affected these numbers, 
as nefrotoxicity was not systematically checked in this retrospective series. The added radiation 
exposure after CTA is on average 2.5mSv per patient. This is equal to 20 months of background 
radiation. There is a debate how radiation exposure due to head CT alters the risk of cancer. 
One study evaluating pediatric patients after 10 years of follow up after head CT, concluded 
that the risk of development of a malignant brain tumor was not raised. However, there was an 
increased risk of development of benign brain tumors.[29] In this study the reason for the CT 
study was unknown. Therefore, ‘reverse causation’ may blur results and give cause to a higher 
reporting of cancer rates than caused by added radiation exposure alone. Another large, recent 
study concluded that the risk of leukemia was tripled when doses exceeding 50mSv were given.
[30] Moreover, the risk of brain tumor was tripled when doses of more than 60mSv were given. 
These doses are nowhere near the dose given for a single CTA. The risk of cancer induction from 
a single combined brain/cervical CTA seems therefore negligible and to outweigh the risk of a 
missed vascular cause of acute headache. 
This is the largest study on the yield of CTA in the group of patients with acute headache, normal 
neurological examination and normal NCCT. By performing a meta-analysis we improved the 
generalizability and precision of our results. 
Our study has limitations. First, we were dependent on studies of varying methodology and with 
varying diagnostic goals and thus the indication for performed CTA may not be completely clear 
and patient series may not have been consecutive. Secondly, not all patient data from studies 
eligible for inclusion could be retrieved, limiting the number of available patients. Unfortunately, 
despite repeated requests additional information was not obtained from three studies. Our 
added data were collected retrospectively and therefore an indication bias for performing CTA 
might have occurred. We cannot deduce how many patients with acute headache did not receive 
a CTA.
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The chance of a finding with clinical implications in the group of patients with acute headache, 
normal examination and normal non-contrast CT is low. However, as any finding of CVT and 
dissection warrants medication change and follow up, the finding of these diagnoses has high 
clinical relevance. RCVS is deemed self-limiting, however consequences of this condition may 
be severe. The number needed to scan in our series to find a clinically relevant abnormality 
(e.g. the probable cause of headache) on CTA, was 61, the number needed to scan to find any 
abnormality was 14. There was only one recorded complication and radiation from CTA is 
relatively low. We therefore conclude that the diagnostic yield of CTA in patients with acute 
headache, normal neurological examination and normal non-contrast head CT is limited but 
because of the consequences for treatment high enough to justify the possible adverse events. 
However, prospective studies to confirm these findings are needed.
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Patients with acute headache increasingly undergo CT-angiography (CTA) to evaluate underlying 
vascular causes. The aim of this study is to determine clinical and non-contrast CT (NCCT) criteria 
to select patients who might benefit from CTA.
Methods 
We retrospectively included patients with acute headache who presented to the emergency 
department of an academic medical center and large regional teaching hospital and underwent 
NCCT and CTA. We identified factors that increased the probability of finding a vascular 
abnormality on CTA, performed multivariable regression analyses and determined discrimination 
with the C-statistic.
Results 
A total of 384 patients underwent NCCT and CTA due to acute headache. NCCT was abnormal 
in 194 patients. Among these, we found abnormalities in 116 cases of which 99 aneurysms. 
In the remaining 190 with normal NCCT we found abnormalities in 12 cases; four unruptured 
aneurysms, three cerebral venous thrombosis‘, two reversible cerebral vasoconstriction 
syndromes, two cervical arterial dissections and one cerebellar infarction. In multivariable 
analysis abnormal NCCT, lowered consciousness and presentation within 6 hours of headache 
onset were independently associated with abnormal CTA. The c-statistic of abnormal NCCT alone 
was 0.80 (95%CI: 0.75-0.80), that also including the other two variables was 0.84 (95%CI: 0.80-
0.88). If NCCT was normal no other factors could help identify patients at risk for abnormalities.
Conclusions 
In patients with acute headache abnormal NCCT is the strongest predictor of a  vascular 
abnormality on CTA. If NCCT is normal no other predictors increase the probability of finding an 
abnormality on CTA and diagnostic yield is low.
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INTRODUCTION
Acute headache may have several vascular causes including subarachnoid hemorrhage 
(SAH) from a ruptured aneurysm, cerebral venous thrombosis (CVT), reversible cerebral 
vasoconstriction syndrome (RCVS) or arterial dissection1-8. These vascular abnormalities can be 
diagnosed in the emergency setting with CT angiography (CTA). 
An additional CTA causes excess radiation exposure of 2.5 mSv after normal NCCT (which also 
causes 2.5mSv9). The iodine contrast which is given intravenously may cause allergic reactions 
and contrast nephropathy in a small number of cases9-11. Therefore, discriminating clinical 
characteristics such as abnormalities on neurological examination to more selectively apply CTA 
would be valuable for physicians in reducing unnecessary diagnostic tests. 
Previous research focused on the value of CTA of the brain and cervical arteries in all 
emergency department patients12 or on development of a clinical decision rule for diagnosing 
SAH, regardless of CTA results, in patients with acute headache13. These studies found that 
several characteristics such as signs of hemorrhage on non-contrast head CT (NCCT), deficit on 
neurological examination, acute onset of headache12, age over 40 years, nuchal rigidity or onset 
during exertion13 are associated with a higher risk of abnormalities on CTA or the chance of 
SAH. A clinical prediction rule for vascular abnormalities on CTA for patients in the emergency 
department with acute headache and a normal NCCT is currently not available. 
In this study we evaluated patients presenting with acute headache in whom CTA was performed 
to exclude secondary forms of headache. We aimed to develop a diagnostic prediction model 
with headache, patient and NCCT characteristics to identify patients with the highest probability 
of an abnormality on CTA. 
MATERIALS AND METHODS
We retrospectively evaluated all patients who underwent a cerebral and cervical CTA between 
January 2011 to December 2014 in the emergency department of the Leiden University Hospital 
(LUMC), a tertiary vascular neurology referral center and university teaching hospital, and the 
Haaglanden Medical Centre in The Hague, a tertiary vascular referral center and a secondary 
teaching hospital. We included all patients who presented with acute headache. We defined 
acute headache as headache peaking within 5 minutes and lasting more than 1 hour. We 
excluded patients who were comatose (EMV <9), who had an ongoing seizure or were otherwise 
unable to express whether they had headache. Patients were also excluded when their headache 
developed after a trauma or after start of focal neurological deficits. 
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The patients were identified in the hospital digital medical chart system by evaluating all patients 
who received a cerebral and cervical CTA and were admitted to the emergency department. All 
medical charts were reviewed for the in- and exclusion criteria. Chart review was done by IMA 
and BFJG with a standardized data abstraction form. We charted patient characteristics (age, 
sex, patient history and medication, focal neurological deficits, seizures, loss of consciousness 
ongoing or of short duration not deemed a seizure, nausea, vomiting, nuchal rigidity, papillary 
edema) and headache characteristics (location, duration, presence of aura, autonomous 
symptoms). 
In the Leiden University Hospital patients were scanned from the aortic arch up to the vertex 
with an Aquilion One (Aquilion ONE, Toshiba Medical Systems, Tokyo, Japan) or Aquilion 64 CT 
scanner (Aquilion 64, Toshiba Medical Systems, Otawara, Japan). In the MC Haaglanden patients 
were scanned from the aortic arch to the vertex with a General Electrics Lightspeed 64-slice 
scanner (General Electric, Chicago Il, USA). 
We recorded adverse events of the CTA including allergic reactions, kidney failure or infections 
after IV catheter use.   The adverse events were deducted from the authorized hospital form 
used to chart any clinical adverse events during admission. 
The study was evaluated and approved by the local ethics committee, which waived the need for 
patient consent as all data were recorded anonymously. 
Statistical analysis
We calculated prevalence ratios with corresponding 95% confidence intervals for patient 
characteristics in relation to presence of abnormalities at CTA.  Multivariable logistic regression 
analysis was performed with a vascular abnormality at CTA as the outcome variable. Candidate 
predictors were considered for entrance into multivariable regression models irrespective of 
their univariable association with a vascular abnormality at CTA14. We included all candidate 
predictors in the multivariable logistic regression model and excluded them stepwise when the 
likelihood ratio test had p>0.15. The discriminative performance, to which the prognostic model 
enables discrimination between patients with and without vascular abnormalities at CTA, was 
described by the c-statistic. The c-statistic varies between 0.5 (a non-informative model) and 1.0 
(a perfect model)15. Our report on prediction adheres to the TRIPOD (Transparent reporting of a 
multivariable prediction model for individual prognosis or diagnosis) guidelines16. This guideline 
consists of a 22 item checklist detailing the essential information that should be included in a 
report of a prediction modeling study.
Some variables, such as papillary edema or nuchal rigidity, were not recorded and thus missing 
in some cases. The absence of these the clinical signs in the examination was also evaluated to 
ascertain whether this was a predictive factor.
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RESULTS
We included 384 patients (flowchart 1). The average age of the participants was 51 years and 
150 (39.1%) were men. In the entire group of patients 129 presented with a normal neurological 
examination (33.6%), 190 had a normal NCCT (49.4%) and 128 had an abnormality on CTA 
(33.3%).  Other characteristics can be found in table 1.
Patients with abnormal NCCT
Of the 194 patients with an abnormal NCCT there were 116 with an abnormality on CTA (59.8%) 
(figure 1). All these abnormalities were symptomatic and were treated accordingly. 128 (74.1%) 
Figure 1. Patient inclusion flowchart.
Legend: ED emergency department, NCCT non-contrast CT, CTA CT angiography, CVT cerebral venous 
thrombosis, AVM arterio-venous malformation, LP Lumbar puncture, RCVS reversible cerebral 
vasoconstriction syndrome, CAD cervical arterial dissection, IH intraparenchymal hemorrhage, SOL space 
occupying lesion
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Table 1. Characteristics of the 384 included patients
Characteristic No. (%)
Age (years) 51; SD 15
Male sex 150 (39.1%)
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patients had SAH on NCCT and in 96 (95.1%) of these patients an aneurysm was found. In two 
patients the CTA showed no abnormalities but an aneurysm was detected after MRI and digital 
subtraction angiography. Three patients with an intraparenchymal hemorrhage also had a 
causative aneurysm on CTA.  The number needed to scan to find a clinically relevant vascular 
abnormality on CTA in this group was less than 2 patients (1.7).
Patients with normal NCCT
In 190 patients (49.5%) the NCCT was normal. Twelve (6.3%) of these patients had a vascular 
abnormality on CTA and in seven (3.7%) of these patients the abnormality was thought to be the 
cause of the headache. These seven abnormalities were also of clinical significance because they 
warranted a change of medication or more intensified follow up. We could not define whether 
the found aneurysms were relevant because we did not have sufficient data to retrieve if they 
had ruptured or not. Unruptured aneurysms are not a likely cause of headache and may be an 
incidental finding. Also data on the necessity of treatment according to our guidelines were not 
completely available. Three patients had CVT, one of which had been diagnosed earlier and was 
unchanged; we did not count this as a relevant finding. Two patients were diagnosed with RCVS, 
two with a cervical arterial dissection and one with a cerebellar infarction. Thus the number 
needed to scan to find a clinically relevant abnormality was 27.
In addition to the clinically relevant findings, unruptured aneurysms were found in four patients; 
in two patients the aneurysms could not be confirmed on MRI, one patient with an MRI confirmed 
aneurysm had a normal LP and the fourth patient did not receive an LP but presented within 6 













Legend: NCCT non contrast CT, SAH subarachnoid hemorrhage, SDH subdural hematoma, CTA CT angiography, 
CVT cerebral venous thrombosis, AVM arterio-venous malformation, RCVS reversible cerebral vasoconstriction 
syndrome, LP lumbar puncture.
Table 1. Continued
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Table 2. Abnormality at CTA in relation to patient characteristics in 384 included patients
Patient characteristics










Age 45-65 years 71/183 (38.8%) 21/119 (17.6%)* 2.20 (1.43-3.38)
Age ≥65 years 36/82 (43.9%) 21/119 (17.6%)* 2.49 (1.57-3.94)
Female sex 79/234 (33.8%) 49/150 (32.7%) 1.03 (0.77-1.38)
Presentation <6h 83/179 (46.4%) 44/204 (21.6%) 2.15 (1.58-2.92)
Unilateral headache 3/30 (10.0%) 125/354 (35.3%) 0.28 (0.10-0.84)
Aura 3/21 (14.3%) 84/296 (28.4%) 0.50 (0.17-1.46)
No Aura recorded 41/67 (61.2%) 87/317 (27.4%) 2.23 (1.72-2.90)
Vomiting 38/186 (20.4%) 76/172 (44.2%) 0.46 (0.33-0.64)
Seizure 3/8 (37.5%) 125/376 (33.2%) 1.13 (0.46-2.79)
Collaps 12/23 (52.2%) 116/361 (32.1%) 1.62 (1.07-2.47)
Altered mental state 4/7 (57.1%) 124/377 (32.9%) 1.74 (0.90-3.35)
Impaired consciousness 24/33 (72.7%) 104/351 (29.6%) 2.45 (1.89-3.20)
Normal glascow coma scale 82/309 (26.5%) 46/75 (61.3%) 0.43 (0.33-0.56)
Nuchal rigidity 25/44 (56.8%) 73/291 (25.1%) 2.26 (1.64-3.14)
Subjective neurological deficit 39/97 (40.2%) 84/282 (29.8%) 1.35 (1.00-1.83)
Pupillary responses abnormal 14/24 (58.3%) 109/353 (30.9%) 1.89 (1.30-2.74)
Motor deficit 19/42 (45.2%) 105/338 (31.1%) 1.46 (1.01-2.11)
Sensory deficit 10/29 (34.5%) 113/350 (32.3%) 1.07 (0.63-1.80)
Neurological examination 
normal
22/129 (17.1%) 106/255 (41.6%) 0.41 (0.27-0.62)
Non Contrast CT normal 12/190 (6.3%) 116/194 (59.8%) 0.11 (0.06-0.18)
Lumbar puncture normal 6/69 (8.7%) 6/29 (20.7%) 0.42 (0.15-1.20)
Lumbar puncture hemorrhage 4/14 (28.6%) 8/84 (9.5%) 3.00 (1.04-8.65)
Lumbar puncture infectious 1/10 (10%) 11/88 (12.5%) 0.80 (0.12-5.67)
Lumbar puncture raised 
pressure
1/4 (25%) 11/94 (11.7%) 2.14 (0.36-12.74)
Neurological history 17/46 (37.0%) 106/333 (31.8%) 1.16 (0.77-1.75)
Headache history 19/82 (23.2%) 106/299 (35.5%) 0.65 (0.43-1.00)
*Age <45 years was taken as a reference
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Multivariable analyses
In the univariable analyses of all 384 patients there were 14 variables associated with either CTA 
abnormalities or normal CTA. Age, presentation within 6 hours of headache, vomiting, collapse, 
impaired consciousness, nuchal rigidity, subjective neurological deficit, abnormal pupil lary 
responses, motor deficit were associated with abnormal CTA. Normal NCCT, unilateral head-
ache, normal neurological examination, normal Glasgow Coma Score and a history of previous 
headaches were associated with normal CTA (Table 2).
In the multivariate analyses three factors were significantly associated with an abnormal CTA: 
presentation within 6 hours of headache, abnormal NCCT and ongoing impaired consciousness 
at time of the NCCT (table 3). The c-statistic of this model was 0.84 (95%CI: 0.80-0.88). A model 
based on clinical characteristics only contained 7 variables (presentation <6h, half sided 
headache, aura, vomiting, nuchal rigidity, pupil abnormalities, and lumbar puncture performed) 
and had a c-statistic of 0.80 (95% CI 0.76-0.85). A model based on NCCT alone had a c statistic of 
0.80 (0.75-0.85). The difference between the c-statistics was not statistically significant.
We attempted to assess which factors would be related to an abnormal CTA in the 190 patients 
with a normal NCCT. However, because there were only 12 patients with a CTA abnormality in 
this group we could not identify these factors as overall yield was low.
Table 3. Multivariable model on basis of clinical characteristics and NCCT
Odds ratio 95% CI
Presentation < 6h 1.82 1.06-3.12
Normal consciousness 0.46 0.24-0.86
Normal NCCT 0.06 0.03-0.11
C statistic 0.84 0.80-0.88
DISCUSSION
We found that the yield of CTA in patients with acute headache presenting at the emergency 
department and an abnormal NCCT is high. An abnormal NCCT was the strongest predictor 
for finding an abnormality on CTA. When combined with the two other clinical factors that 
contributed independently to finding an abnormal CTA, an impaired lowered consciousness and 
presentation within 6 hours of headache, discrimination was not better than when NCCT alone 
was used. In patients with normal NCCT the diagnostic yield was low and in only seven out of 190 
patients a clinical relevant abnormality was found. 
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As far as we are aware this is the first study focusing on a prediction model for finding an abnor-
mality on CTA in acute headache focusing on a broader diagnostic range than just SAH. We 
included patients from an academic medical center and a large teaching hospital to improve the 
generalizability of our results.
Our study has several limitations. First, there is a likely selection bias in the performed CTAs 
limiting the number of CTAs in patients with normal NCCT or normal neurological examination. 
Due to the retrospective design of our study we do not know why the treating physician chose 
to perform these CTAs and more importantly, we cannot determine how many patients did not 
receive a CTA at all. Second, in some subgroups, such as patients with a normal NCCT, the number 
of abnormalities was small. Due to the limited number of abnormalities there was insufficient 
power to determine clinically relevant factors. Alternatively, one could reason that abnormalities 
in this group are so few that CTA scanning in these patients is not cost-effective. Finally, we had 
to rely on retrospective chart review and some data, for instance on the presence of nuchal 
rigidity or evaluation of papillary edema, was missing in a large part of patients, because the 
performance of such neurological tests may very much depend on the severity of the clinical 
presentation. 
Patients with acute headache and an abnormal NCCT should receive CTA. The yield of CTA in 
patients with a normal NCCT was low and the number needed to scan to find a clinically relevant 
abnormality was 27. We feel this may still warrant CTA in this group, particularly if high diagnostic 
sensitivity is strived for.  Clinically relevant diseases such as RVCS or CVT may be missed without 
additional imaging of the vessels. A prospective study aimed at identifying criteria for selecting 
patients with a normal NCCT for CTA is therefore needed. 
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Patients presenting with sudden severe headache may have a subarachnoid hemorrhage, (SAH). 
After a normal head Computer Tomography (CT) a lumbar puncture (LP) is routinely performed 
to rule out SAH. Photospectrometry is then used to detect bilirubin in cerebrospinal fluid (CSF). 
Photospectometric analysis of CSF reaches a high sensitivity but a low specificity for SAH. 
This low specificity necessitates extensive additional research to rule out cerebral aneurysm 
accompanied by high costs and risk of complications.
Objective
The objective of this study was to retrospectively evaluate two different CSF interpretation 
methods using photospectrometry in patients presenting with acute headache. The first of these 
is the Leiden method, an iterative model using a standard calculation. The second is the UK 
NEQAS guideline, which uses the original spectrum in combination with a decision tree. Our goal 
was to obtain retrospective data on patients screened with both methods to improve specificity 
of CSF research.
Results
We included 361 patients in this study, 47 of these had a raised bilirubin concentration in the 
CSF according to the Leiden method. In only 9 of these 47 patients an aneurysm was found, 
in the other patients the Leiden test was positive due to other reasons (viral meningitis, 
hyperbilirubinemia  e.a.) Out of the 47 patients with raised bilirubin, 24 could be re-evaluated 
using the UK NEQAS. Of these 24 patients, 5 had an aneurysm. There were no aneurysms found 
in patients with a negative result according to the UK NEQAS guideline. 
Conclusion
Our data show that a raised bilirubin calculated using the Leiden method seems to have a lower 
specificity than the UK NEQAS guideline. For practical reasons, it seems advantageous to use 
the Leiden method as a screening method, and use the UK NEQAS guideline if a positive result 
is found.
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INTRODUCTION
Acute headache is a frequently encountered complaint in the emergency room and can be a 
presenting sign of subarachnoid haemorrhage (SAH). It is common practice to first perform a 
Computerized Tomography (CT) of the brain to exclude haemorrhage. The sensitivity of CT is 
high, almost 100%, in the first 12 hours but this declines to 58% after 5 days [1;2]. In a recent study 
third generation CT was evaluated with a sensitivity of 100% within the first 6 hours and 85.7% 
after 6 hours [3]. When there is a high suspicion of SAH it is common practice to subsequently 
perform a lumbar puncture (LP). Although this practice has been questioned, recent research 
shows that a LP is still obligatory to exclude an SAH, especially if the patient presents several 
days after the headache [4;5]. 
Haemolysis of erythrocytes in the cerebrospinal fluid (CSF) leads to release of oxyhaemoglobin, 
which is subsequently degraded to bilirubin by the mononuclear phagocyte system. 
Oxyhaemoglobin (and methaemoglobin) can also be introduced into the CSF by a traumatic 
puncture and thus may not be conclusive [6]. In contrast, bilirubin levels rise to detectable amounts 
in the course of approximately 12 hours after an SAH by in vivo conversion of haemoglobin 
and remains detectable in the CSF for 2-4 weeks after haemorrhage [7]. The presence of the 
metabolites of erythrocytes in CSF can often be detected by the yellowish appearance of the 
CSF, called xanthochromia. However, visual inspection of CSF for xanthochromia lacks adequate 
sensitivity and specificity [8;9;10], so analysis of CSF with UV/VIS-spectrophotometry is often 
used to qualitively and/or quantitively measure levels of oxy-, methaemoglobin and bilirubin. 
Currently, in the Netherlands, either an iterative calculation model (Leiden method) [10] or the 
revised British national guidelines using a decision tree (UK NEQAS guideline) [11] are used to 
improve the interpretation of the UV/VIS-spectrum of blood pigments in CSF. Sensitivity in CSF-
spectrometry methods has been reported to be 100%, however, published specificities of 75 and 
83% leave room for improvement [8;12]. 
The objective of this study was to evaluate and compare the Leiden and UK NEQAS methods in 
clinical practice and to present an optimal approach for blood pigment analysis to reduce the 




Here we describe a retrospective study researching the clinical outcomes of patients presenting 
in the emergency room from January 2008 through May 2011 with severe, acute, non-traumatic 
headache, in correspondence to their LP analysis. Patients with pathological findings on standard 
head CT, such as SAH or subdural hematoma were excluded. If available, neuro-imaging 
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results of CT-angiogram, angiography and MRI were reviewed. In accordance to the hospital’s 
protocol, LP’s were performed at least 12 hours after the onset of symptoms and CSF protein 
and glucose concentrations were determined. Collected samples were transported to the in-
house laboratory constantly shaded from light. Cell-counts for erythrocytes and leucocytes were 
carried out routinely. The Leiden method was used clinically for CSF analysis. There were no 
specific ethical concerns or need for informed consent as patients were examined and treated 
according to current clinical practice. 
Assays
Automated assays
Total protein in CSF was measured turbidimetrically after the addition of benzethoniumchloride. 
Glucose in CSF was determined with the hexokinase-method. Plasma total bilirubin was 
measured photometrically after reacting with diazonium. All automated assays were performed 
on a Modular analyser (Roche, Almere, The Netherlands). 
CSF sample handling and UV-spectrum measurement
CSF samples obtained from the LP were directly taken to the in-house clinical laboratory. 
The least blood-stained specimens were used for analysis. After a visual inspection and cell-
count, samples were centrifuged for 5 minutes at 1250 g, within 1 hour after LP. Then 100 μl 
of 0.25 M phosphate buffer pH 6.6 was added to 900 μl of CSF to rule out pH-influences on 
the UV-absorption characteristics [10]. The sample was transferred into a cuvette with a 1 cm 
path length. Subsequently, absorbance spectra were made from 350 to 700 nm on a Thermo 
Evolution 300 using Thermo Vision software (Thermo Scientific, Breda, The Netherlands) using 
demineralised water as a blank reference.  
Interpretation methods
Iterative calculation model (‘Leiden method’)
To calculate the concentrations of methemoglobin, oxyhemoglobin and bilirubin using an 
iterative model the method described by Duiser et al. [10] was used. This method requires the 
Duisersoft Microsoft Excell program (obtained from dr. Duiser). The absorption values at 360, 
405, 414 and 455 nm were transferred into this program, which instantly produces a model-
spectrum and calculates the concentrations of the various blood pigments. As recommended, 
bilirubin CSF concentration > 0.2 μmol/L were considered higher than the upper reference value 
[12] indicating the possibility of an SAH. Values ≤ 0.2 μmol/L were interpreted as ‘negative’.
Net bilirubin absorbance (‘UK NEQAS guideline’)
As an alternative to the iterative model, the spectra of the 118 most recent specimens were 
also retrospectively interpreted according to the revised UK NEQAS guideline [12]. In contrast to 
the guideline, the samples were diluted to a small extent due to the addition of the phosphate 
buffer used in the Leiden method. However, the implications for a correct estimation of the 
net bilirubin absorbance (NBA) were considered insignificant since the dilution was minimal 
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and equally present in all samples. A predicted baseline was drawn in the original spectrum 
and the NBA was measured at 476 nm. At the same time, the net oxyhemoglobin absorbance 
(NOA) was determined using the predicted baseline and the absorbance maximum between 
410-418 nm. Subsequently, the interpretation of the specimens was done using the decision 
tree as described in the guideline, taking into account the NBA, NOA and serum bilirubin and 
CSF total protein concentrations. Interpretations were categorized into: ‘inconclusive’ (due to 
high NOA), ‘no evidence to support SAH’, ‘consistent with SAH’ and ‘interpret with caution’ (due 
to CSF protein ≥1.0 g/L). 
Patient diagnosis
All digital patient files were searched retrospectively to determine clinical diagnosis. When 
performed, Computer Tomography Angiogram (CT-A), Magnetic Resonance Imaging (MRI) and 
Angiography (DSA) were reviewed to establish their contribution to the diagnosis. At least four 
months after the inclusion patient statuses were revised for missed SAHs or altered diagnosis.
RESULTS 
Between January 2008 and May 2011 the CSFs of 361 patients presenting with acute headache 
were analysed for blood pigments. This cohort was comprised of 234 women (64.5 %) and 
127 men, with a mean age of 43.5 years. According to our hospital protocol CSF samples were 
originally evaluated with the Leiden method. Of all patients included in the study, 47 had 
a bilirubin concentration of 0.3 μmol/L or higher (13%) in their CSF and 314 were ‘negative’ 
according to the Leiden method. Of the 47 patients found to be ‘positive’, 25 received a CT 
angiogram, which lead tot the diagnosis of aneurysm in seven patients and sinus thrombosis 
in two patients The lowest CSF bilirubin concentration in a patient with a confirmed SAH was 
0.3 μmol/L. 15 CT angiograms were normal, although two patients with a normal CT angiogram 
were later diagnosed with an aneurysm after MRI and angiography. Three more patients had an 
MRI, of which one was normal, one showed hydrocephalus and one showed a sinus thrombosis. 
Of the 19 patients with a positive bilirubin who did not get a CT angiogram or MRI, six had a viral 
meningitis, one had had a traumatic LP three days prior showing 1030 erytrocytes and a normal 
bilirubin count, one had hyperbilirubinemia and 11 did not receive additional neuro-imaging. 
According to digital patient files after 4 months follow-up none of our patients with a negative 
CSF result has had a SAH. We cannot however exclude the possibility that patients might have 
been seen in another neurosurgical centre. The reason for lack of further diagnostics in these 
cases could not be determined, but in most cases was likely due to low clinical suspicion of SAH.
Of all 361 patients 117 could be re-evaluated using the UK NEQAS guideline. Seven patients 
were ‘consistent with SAH’ (6%), 99 spectra were interpreted as ‘no evidence to support SAH’. 
Three patients had an incorrect spectrum recording and one had an inconclusive spectrum due 
to a severe traumatic puncture. Seven patients were classified as ‘interpret with caution’ due to 
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high CSF protein concentrations (>1 g/l). The high protein concentrations could be attributed 
to (bacterial) meningitis (five patients) and severe traumatic punctures (two patients with 
erythrocyte counts >100000).
Of the 47 patients that were considered ‘positive’ according to the Leiden method it was possible 
to re-evaluate 23 with the UK NEQAS guideline. Six of these patients were also positive using the 
UK NEQAS guideline (Tabel 1). 
Of these ‘double positive’ patients one did not receive a CT angiogram, but of the other five that 
did, four had an aneurysm on the CT angiogram, and one an aneurysm after MRI. All the patients 
that were negative with the Leiden method were also negative using the UK NEQAS guideline. 
There were no patients that were positive with the UK NEQAS guideline that were diagnosed with 
another underlying disease such as viral meningitis, sinus thrombosis or otherwise. One patient 
with a ‘no evidence to support SAH’ result following the UK NEQAS guideline was classified as 
having an aneurysm, however this aneurysm had already been discovered earlier and had been 
coiled. This patient presented because of a second episode of acute headache. 
DISCUSSION
In this study we set out to compare the UK NEQAS guideline and the Leiden method for the 
interpretation of blood pigment analysis in CSF in patients with acute headache and a normal 
CT. Our results show that less patients are considered ‘positive’ using the UK NEQAS guideline 
(13% vs. 6%). Confounders in the Leiden method are viral and bacterial meningitis and sinus 
thrombosis, but incorrect spectrum recordings were recorded. This last confounder can be 
explained by high baseline levels recorded with the Leiden method, caused by spurious UV-
absorption (e.g. non-centrifuged samples) resulting in falsely elevated bilirubin levels in the 
iterative calculation model. In five patients that were positive with the Leiden method (up to 0.6 
μmol/L) the UK NEQAS guideline resulted in a negative result without a clear reason, indicating 
that the cut-off value of 0.007 AU in the UK NEQAS guideline is more conservative. However, as 
one patient had a confirmed SAH with a CSF bilirubin concentration of 0.3 μmol/L, a higher cut-
off value for the Leiden method does not seem feasible. 
In earlier studies a high sensitivity has been reported for both the Leiden method and the UK 
NEQAS guideline of up to 100% [8;12], but, due to a lack of a gold standard for SAH diagnosis we 
state that it is impossible to calculate a reliable sensitivity and specificity. A previously published 
prospective study performed a follow-up after ‘normal’ CT and CSF results and found no patients 
with SAH. However, in that study one patient was diagnosed with an aneurysm after a MRI [4]. 
We find similar results; in our study a SAH was discovered with MRI and angiography in two 
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F, 58 0.8 Consistent with SAH 10443 16 0.4 Not performed
F, 61 6 Consistent with SAH 17000 21 0.66 Normal
F, 45 4.5 Consistent with SAH 20000 209 0.59 Aneurysm
F, 46 1 Consistent with SAH 191000 296 1.15 Aneurysm
M, 53 0.9 Consistent with SAH 40 12 0.34 Aneurysm
F, 69 0.3 Consistent with SAH 78 10 0.6 Aneurysm
F, 52 0.6 No evidence of SAH 830 2 0.3 Normal
M, 53 0.4 No evidence of SAH 25000 19 1.01 Not performed
M, 51 0.3 No evidence of SAH 61 3 0.36 Not performed
M, 39 0.3 No evidence of SAH 23 2 0.48 Not performed
F, 42 0.3 No evidence of SAH 47000 76 0.92 Normal
F, 23 0.3 No evidence of SAH 14933 2 0.78 Normal
M, 48 0.6 TP >1g/l, caution 113000 0 3.18 Normal
F, 57 0.5 TP >1g/l, caution 118000 56 1.36 Normal
F, 57 0.4 TP >1g/l, caution 13 32 1.2 Normal
M, 19 0.3 TP >1g/l, caution 360 280 1.0 Not performed
F, 38 4.2 TP >1g/l, caution 1348 128 1.41 Normal
M, 84 † 0.9 TP >1g/l, caution 352 3200 4.21 Not performed
F, 54 0.3 TP >1g/l, caution 170 1944 1.67 Not performed
M, 44 0.8 NOA >0.1, 
inconclusive
435000 180 5.35 Tumor mass
M, 16 0.6 ‘Wrong spectrum’ 8 0 0.3 Normal
M, 32 0.3 ‘Wrong spectrum’ n.d. n.d. 0.39 Not performed
F, 47 2.2 ‘Wrong spectrum’ 121 2 1.0 Aneurysm
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patients after a normal CT angiography. If we were to calculate the sensitivity of the Leiden 
method and the UK NEQAS guideline this would amount to 100% for both methods in this series. 
Specificity of the Leiden method was 89%, while specificity of the UK NEQAS method was 99%. 
In our study, we evaluated the use of the Leiden method for primary CSF interpretation and, 
in case of a ‘positive’ outcome, the use of the UK NEQAS guideline as a secondary method 
to optimize specificity. This approach was taken since the UK NEQAS guideline, although it 
appears to have superior specificity, has some practical disadvantages: interpretation has to be 
performed by an experienced interpreter and CSF protein and serum bilirubin concentrations 
are mandatory variables [11]. In addition, the time of onset of the symptoms should be taken 
into account [11;13] and many other variables such as CSF glucose and leucocyte count, recent 
traumatic punctures and/or light exposure may, although not incorporated in the UK NEQAS 
guideline, provide crucial information.The Leiden method, on the other hand, has little inter-
person variation and a relatively simple workflow [11]. Our data show that by using the Leiden 
method as a screening tool about 87% of the patients can be diagnosed as ‘no evidence to 
support SAH’ as the UK NEQAS guideline and clinical outcome confirmed all these ‘negative’ 
patients. In only 13% of the cases an experienced technician or clinical chemist is required for 
alternative CSF interpretation using the UK NEQAS guideline. As fast CSF interpretation is highly 
recommended [11], the workflow we propose has practical benefits, especially during out-of-
office hours. Moreover, the increase in specificity following this workflow may, due to the low 
incidence of SAHs in our population (approx. 3%), lead to a significant reduction in potentially 
harmful and costly imaging techniques 
CONCLUSION
Based upon our retrospective evaluation of two CSF interpretation methods in 361 patients 
with suspicion of a SAH we propose to first perform the Leiden method and in case of a positive 
result, use the UK NEQAS guideline as a secondary diagnostic method. Using the workflow we 
propose optimal specificity is achieved with high practicality for clinical laboratories.
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Bacterial meningitis is a severe but treatable condition. Clinical symptoms may be ambiguous 
and current diagnostics lack sensitivity and specificity, complicating diagnosis. Procalcitonin 
(PCT) is a protein that is elevated in serum in bacterial infection. We aimed to assess the value of 
PCT in cerebrospinal fluid (CSF) in the diagnosis of bacterial meningitis.
Methods 
We included patients with bacterial meningitis, both community acquired and post neuro-
surgery. We included two comparison groups: patients with viral meningitis and patients who 
underwent lumbar punctures for non-infectious indications. We calculated mean differences 
and 95% con fi dence intervals of procalcitonin in CSF and plasma in patients with and without 
bacterial meningitis.
Results 
Average PCT concentrations in CSF were 0.60 ng/ml (95%CI:0.29-0.92) in the bacterial meningitis 
group (n=26), 0.81 (95%CI:0.33-1.28) in community-acquired meningitis (n=16) and 0.28 
(95%CI:0.10-0.45) in post-neurosurgical meningitis (n=10), 0.10 ng/ml (95%CI 0.08-0.12) in the 
viral meningitis group (n=14) and 0.08 ng/ml (95%CI:0.06-0.09) in the non-infectious group (n=14). 
Mean difference of PCT-CSF between patients with community-acquired bacterial meningitis 
and with viral meningitis was 0.71 ng/ml (95%CI:0.17-1.25) and 0.73 ng/ml (95%CI:0.19-1.27) for 
community-acquired bacterial meningitis versus the non-infectious group. The median PCT CSF: 
plasma ratio was 5.18 in post-neurosurgical and 0.18 in community-acquired meningitis (IQR 
4.69 vs. 0.28).
Conclusion 
Procalcitonin in CSF was significantly higher in patients with bacterial meningitis when compared 
with patients with viral or no meningitis. PCT in CSF may be a valuable marker in diagnosing 
bacterial meningitis, and could become especially useful in patients after neurosurgery.
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INTRODUCTION
Bacterial meningitis is a life threatening but, treatable condition with high morbidity (20%) and 
mortality (15%) [1]. The gold standard in diagnosing bacterial meningitis is by demonstrating 
the presence of bacteria in cerebrospinal fluid (CSF) samples via gram staining or CSF cultures. 
In the acute setting however, bacterial cultures take too much time to be used in the decision 
whether or not to start antibacterial treatment. Polynuclear pleiocytosis combined with raised 
CSF protein and lowered CSF glucose indicate bacterial meningitis, but these findings are not 
sensitive and may not be present in 12% of patients [2-4]. These parameters are even more 
unreliable in patients with an extraventricular drain (EVD) after subarachnoid- or intracranial 
hemorrhage as intrathecal plasma leakage causes raised erythrocytes and leucocytes counts 
[5]. An additional diagnostic marker to distinguish bacterial meningitis from aseptic, viral or no 
meningitis would therefore be valuable.
Procalcitonin (PCT) is a protein that can be released by parenchymal cells in the presence of 
endotoxins or cytokines like interleukin-6 and tumor necrosis factor-α. PCT is raised strongly 
during bacterial inflammation, but not or only marginally elevated in viral or non-infectious 
inflammatory reactions [6,7]. Whether it is locally produced in the central nervous system is 
a matter of debate, but calcitonin messenger RNA has been isolated in hamster brain tissue 
suggesting this possibility [8]. A recent study showed that procalcitonin is produced by trigeminal 
glia cells in response to inflammation, making local production in the central nervous system 
more likely [9].
Availability of the PCT-assay on standard immunochemistry platforms allows turn-around-
times within an hour, making the test suitable in an acute setting. PCT has been proven to be 
valuable in differentiating between bacterial and viral meningitis when determined in serum 
[10-12]. However, the usefulness of PCT in serum of patients with bacterial meningitis after 
neuro-surgical intervention is limited [13]. Previous studies of PCT measurement in CSF have 
shown conflicting outcomes. Two studies showed significantly higher PCT concentrations in CSF 
in patients with bacterial meningitis compared with tick-borne encephalitis or viral meningitis 
[14,15]. Others have suggested that the level of PCT in CSF did not differ between bacterial 
and viral meningitis [16]. Methodological factors may explain these conflicting findings. As the 
analytical performance of the PCT assay has improved since these studies, renewed investigation 
is warranted.
The aim of this study is to investigate whether there PCT levels in CSF in patients with bacterial 
meningitis are elevated and whether this could be a potential marker to differentiate between 
the presence or absence of bacterial meningitis. 
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From September 2012 to February 2015 we prospectively included adult patients (>18 years) who 
underwent a lumbar puncture on clinical suspicion of bacterial meningitis. Patients presented 
either to the emergency room, were admitted or were seen as inpatients in our secondary 
teaching hospital. We aimed to study consecutive patients, however, a small number of patients 
were missed when seen during on call hours.
The study protocol was evaluated and approved by the local ethics committee. The ethics 
committee waived the need for consent to participate as PCT was determined in already 
available CSF and plasma samples (remnants) and no additional sample volumes were taken for 
the purpose of this study. Patients were investigated and treated according to current clinical 
practice and were not personally subjected to additional testing or questionnaires. 
We divided patients into three groups depending on the outcome of standard CSF examination. 
First a bacterial meningitis group, both community acquired (CAM) or after neurosurgical 
procedure (PNM), second a comparison group with viral meningitis and finally a comparison 
group who underwent lumbar puncture for non-infectious reasons. 
Patients were diagnosed with bacterial meningitis if CSF testing showed polynuclear pleocytosis 
with leucocyte count >2000x106/l CSF leucocytes, raised CSF protein > 2.2 g/l, lowered CSF 
glucose <1.9 mmol/l or a CSF:plasma glucose ratio <0.23. Positive CSF culture, if available, was 
used as diagnostic gold standard. These conditions have been proven to be 88-99% accurate 
individual predictors of bacterial meningitis [2,3]. Our bacterial meningitis group consisted 
of patients with community acquired meningitis (CAM) and patients with post neuro-surgical 
intervention meningitis (PNM). The interventions in the PNM group consisted of placement of 
an EVD or craniotomy. By using the same CSF chemistry criteria for the PNM group we aimed to 
collect not only a homogenous group with bacterial meningitis but also to exclude patients with 
aseptic meningitis. Second, we hoped to evaluate the differences in PCT outcome between CAM 
and PNM groups with similar CSF chemistry. 
The first comparison group consisted of patients with viral meningitis. A positive PCR was used 
as gold standard where available. Patients were diagnosed with viral meningitis if CSF testing 
showed mononuclear pleocytosis with leucocyte count >5x106/l, but normal glucose and pos-
sibly raised protein. 
The second comparison group consisted of patients free of infection. The selection criteria for 
this group were that patients were free of fever (T <38◦C) and the indication for the LP was 
unrelated to excluding infectious disease (eg. hemorrhage in acute headache), additionally 
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normal plasma C-reactive protein (<5 mg/l), normal CSF leucocyte count (<5x106/l) and normal 
CSF glucose (>1.9 mmol/l) and protein (<2.2 l) were mandatory inclusion criteria for this group.
We collected data on clinical characteristics, such as presence of headache, fever, depressed 
level of consciousness, nuchal rigidity and whether bacterial cultures were positive and with 
which pathogen.
Sample handling and assays
Lumbar punctures were performed and plasma was obtained before the start of treatment. PCT 
was determined from the same CSF that prompted a diagnosis of bacterial meningitis or not. The 
PCT results were not visible for clinicians during diagnosis or treatment. CSF samples obtained 
from the lumbar puncture were taken to the in-house clinical laboratory within 20 minutes. The 
least blood-stained specimens were used for analysis. After a visual inspection and cell-count, 
samples were centrifuged for 5 minutes at 1250 g, within 1 hour after lumbar puncture. Total 
protein in CSF was measured turbidimetrically after adding benzethoniumchloride, glucose 
levels were determined with the hexokinase-method and CRP by immunoturbidimetry. Plasma 
and CSF procalcitonin were measured with the BRAHMS Elecsys two step-immunoassay. If 
direct measurement of PCT was not possible samples (CSF and/or plasma) were stored at – 20⁰C 
within 24 hours. The functional sensitivity of the PCT assay was <0.06 ng/ml, with an analytical 
sensitivity of <0.02 ng/ml. There is a reported variation coefficient of < 10% at a concentration 
of 0.04 ng/ml in plasma [17]. All automated immunochemistry assays were done on a Modular 
analyser (Roche, Almere, The Netherlands). Standard CSF chemistry and PCT determination 
were evaluated by the hospital clinical chemist.
Reported reference plasma PCT concentration in healthy adults is <0.10 ng/ml. Reference values 
for PCT in CSF are unknown [17]. Plasma PCT was not determined in the two comparison groups.
Statistical analysis
We calculated mean differences in PCT levels between patients with and without bacterial 
meningitis, as well as accompanying 95% confidence intervals (CI). If the 95% confidence interval 
for the difference does not contain the value 0, the difference is statistically significant and p<0.05. 
For comparison of PCT in plasma and PCT ratios in CSF versus plasma between groups we used 
the Mann-Whitney U test because the data of these variables were not normally distributed. 
For these data we gave medians and interquartile ranges (IQR’s). To assess the discriminative 
property for PCT in CSF we made ROC curves and calculated the area under the curve comparing 
patient groups with an infection (bacterial meningitis, both CAM and PNM, and viral meningitis) 
with the patients without an infection. 
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We included 26 patients with bacterial meningitis; 16 patients with community acquired and 
10 patients with bacterial meningitis after neurosurgical intervention. We excluded 4 patients 
with bacterial meningitis who clinically were treated as such, but did not meet the criteria 
set in advance for CSF diagnosis. Of the PNM patients four had an EVD and six a craniotomy. 
There were 13 positive CSF cultures among the 26 patients; three Pneumococcus pneumonia, 
three Staphylococcus epidermidis, two Neisseria meningitides, one Heamophilus influenza, 
one Escherichia coli, one Streptoccus mitis, one Streptococcus pneumoniae and one Listeria 
monocytogenes. The CSF cultures of the remaining patients were negative. In the comparison 
groups we included 14 patients with viral meningitis and 14 patients without infection. In 
patients with viral meningitis PCR was positive for Enterovirus in three cases, Herpes Simplex-2 
in one case and Varicella Zoster in the last case. In these groups no patients were excluded. 
Patient characteristics and results are shown in tables 1 and 2.
The average PCT in CSF in the group of bacterial meningitis patients was 0.61 ng/ml (95%CI 0.27-
0.93). The PCT in CSF in the group of patients with bacterial meningitis was significantly higher 
when compared with viral meningitis and the group without infection PCT in CSF (table 2). PCT 
in CSF was not significantly different between CAM or PNM patients (mean difference 0.53 ng/
ml; 95% CI -0.13-1.19). The PCT in CSF of the PNM patients was significantly higher than the viral 
meningitis group and the group without infection (figure 1, table 2).
Figure 1. Scatter plots of procalcitonin in cerebrospinal fluid in the studied groups. Horizontal bar represents 
the mean value of a group, logarithmic scale.
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The median PCT in plasma of the entire bacterial meningitis group was 0.50 ng/ml (IQR 4.36). The 
median levels of PCT in plasma showed a statistically significant difference between the bacterial 
and viral meningitis groups (p=<0.001). The median plasma PCT in the PNM group of 0.05 ng/ml 
(IQR 0.08) was significantly lower than that in the CAM group of 1.28 ng/ml (IQR 6.82) (p=<0.001) 
(figure 2). Five out of ten patients (50%) in de PNM group had plasma PCT levels within the 
reported reference range of <0.1 ng/ml. 
The PCT CSF: plasma ratio was significantly higher in PNM patients (median 5.18, IQR 4.69) than 
in patients with CAM (median 0.18, IQR 0.27) (p<0.001), due to a higher PCT in CSF in comparison 
with PCT plasma levels in PNM patients (figure 3). We also compared these ratios between 
patients with low and high erythrocyte counts (< 40 and ≥2000x106/l erytrocytes) in order to 
ascertain whether outcome was influenced by traumatic lumbar puncture both in patients with 
CAM and PNM. In the CAM group, nine patients had ≥2000x106/l erythrocytes in CSF and five 
CAM patients had an erythrocyte count <40 x106/l. The PCT CSF:plasma ratio in these groups was 
not significantly different (ery’s <40 median 0.18, IQR 0.31, ery’s >2000 median 0.33, IQR 0.25) 
(p=1). In PNM eight patients had ≥2000x106/l erythrocytes in the CSF. In this group the median 
PCT CSF: plasma ratio was 5.18 (IQR 3.18). Only one patient had <40x106/l erythrocytes in his 
CSF with a CSF: plasma ratio of 1.6. The final PNM patient had 597x106/l erythrocytes and a PCT 
CSF:plasma ratio of 9.3.
We also compared PCT levels in patients diagnosed with bacterial meningitis with and without 
posi tive bacterial CSF cultures. The average PCT in CSF of patients with a positive culture was 
0.82 ng/ml (SD 1.03, N=13). The average PCT in CSF of patients with a negative culture was 
Figure 2. Scatter plots of procalcitonin in plasma in the studied groups. Horizontal bar represents the mean 
value of a group, logarithmic scale. The dotted line represents procalcitonin normal value in plasma.
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0.41 ng/ml (SD 0.35, N=13). The difference between these levels was not statistically significant 
(mean difference 0.41 ng/ml; 95% CI -0.18-1.00).In the PNM group four patients received an 
external ventricular drain and six underwent a craniotomy. Statistical analysis showed no effect 
of type of neurological surgery on PCT values (mean difference 0.06; 95%CI:-0.39-0.51). PCT 
in plasma was not significantly lower in patients after EVD than in patients after craniotomy 
(mean difference 0.16; 95%CI:-0.06-0.38). However the confidence interval is wide due to the 
small patient subgroup. In PNM three CSF cultures were positive which were all found in the 
craniotomy group.
The receiver-operator curve (ROC) for PCT in CSF of patients with bacterial meningitis versus 
the patients without an infection had an area under the curve (AUC) of 0.93 (95% CI 0.86-1.00). 
The AUC of the ROC for the CAM vs. the group of patients without an infection was 0.90 (95% CI 
0.78-1.00) and PNM vs. group of patients without an infection was 0.99 (95%CI 0.96-1.00). The 
AUC of the ROC for viral meningitis vs. the group of patients without an infection was 0.67 (95% 
CI 0.47-0.87) (figure 4).
In order to be able to calculate sensitivity specificity and positive and predictive value, we chose a 
cut off value for PCT in CSF based on our reference groups. We arbitrarily chose a cutoff value for 
PCT in CSF of >0.9 ng/ml. This is the upper limit of the 95% CI of PCT in CSF in the non-infectious 
group. With this cutoff value we found a sensitivity of 92% (95% CI 75-99%) and a specificity of 
68% (95% CI 48-84%). Positive predictive value is 73% (95% CI 55-87%) and negative predictive 
value is 90% (95% CI 70-99%).
Figure 3. Scatter plots of procalcitonin plasma:CSF ratio. Horizontal bar represents the mean value of a group, 
logarithmic scale.
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Figure 4. ROC curves for PCT in CSF compared to non-infectious patients for A: all bacterial meningitis 
patients, area under the curve (AUC) 0.93, B: community acquired meningitis. AUC 0.90, C: post neurosurgical 
meningitis, AUC 0.98, D: viral meningitis, AUC 0.67.
DISCUSSION
Our results show that in our patient population PCT in CSF is significantly higher in patients with 
bacterial meningitis when compared to patients from the two comparison groups: viral meningitis 
and the group of patients without an infection. This counts for patients with community acquired 
meningitis as well as patients with meningitis after a neurosurgical procedure.
PCT in plasma of patients with bacterial meningitis was significantly higher than that of patients 
with viral meningitis. But PCT in plasma of the PNM group was not significantly higher than in the 
viral meningitis comparison group. For this subgroup PCT in plasma seems less sensitive than 
519320-L-bw-Alons
Processed on: 2-5-2018 PDF page: 76
76
Chapter 6
PCT in CSF. This finding corresponds with an earlier study that evaluated the use of PCT in serum 
of post-neurosurgical patients and found that in serum sensitivity of PCT is low for diagnosing 
bacterial meningitis [13]. 
The findings above raise the question whether there is intrathecal production of PCT. Due 
to its large molecular structure (13kDa) and being a protein, it is unlikely that PCT passes the 
blood brain barrier in healthy adults [18]. However, in meningitis the blood brain barrier may be 
compromised due to infectious processes. Similarly, traumatic lumbar puncture may confound 
results by plasma leakage. Most of our bacterial meningitis samples had high erythrocyte counts 
(see table 2). However, when patients with low or high erythrocyte counts with CAM and PNM 
were grouped and compared, PCT ratios were the same irrespective of erythrocyte count. This 
makes it highly unlikely that the elevated PCT in CSF originates from leakage of PCT plasma 
through the blood brain barrier or traumatic lumbar puncture. 
Strikingly, the CSF:plasma ratio of PCT was significantly higher in the PNM group compared with 
the CAM patients. This indicates a much stronger increase of PCT in CSF than in plasma in the 
PNM group. Moreover, most plasma PCT levels in the PNM group were within the reported 
reference range of < 0.10ng/ml. We hypothesize this skewed distribution in favor of PCT in CSF 
in the PNM group may be due to a direct bacterial port of entry after neuro-surgery and the 
lower level of systemic infection in these patients. We surmise PCT levels may only become 
raised in blood if bacterial meningitis is accompanied by systemic infection or sepsis, as is the 
case in most CAM patients. For patients with PNM determining PCT in CSF may become useful 
as a diagnostic marker.
Our study has limitations. First, study size is relatively small, limiting the power of the study. 
However, despite the small number of patients we still found a significant difference between 
groups, with confidence intervals that are sufficiently narrow to allow precise determination of 
between group differences. Second, we could not prove the presence of meningitis in all patients 
by means of a positive CSF culture, resulting in potential bias due to miss-classification. Since 
only 44% of patients have all characteristics of bacterial meningitis [2] we may have included 
patients in the wrong group. To diminish this possibly important methodological shortcoming 
we used international CSF diagnostic values which are individual positive predictors in 88-99% 
[2,3]. In choosing these parameters we also hoped to bypass the chance of diagnosing aseptic 
meningitis as bacterial meningitis. The downside of using these set parameters was that we 
could not calculate the added value of PCT against the conventional diagnostic markers. The 
calculation of an ROC curve of PCT in CSF vs. leucocyte count for instance was not possible. 
We calculated whether there was a difference in PCT levels in CSF in patients diagnosed with 
bacterial meningitis with a positive and negative bacterial CSF culture and found that the 
difference is not statistically significant. This supports our correct selection of patients for the 
bacterial meningitis group based on CSF chemistry.
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Finally, there are no reference values for PCT in CSF available. By including a group with major 
headache as complaint and no CSF abnormalities we aimed to include a ‘best-available’ reference 
group for CSF PCT. We arbitrarily determined a theoretical reference value based on the upper 
limit of the 95% CI of PCT in CSF for the non-infectious group. With this value we calculated 
sensitivity, specificity, negative predictive and positive predictive value for PCT in CST. These 
results show a good sensitivity and negative predictive value, but need to been seen only as a 
measure for easier interpretation of the outcomes; they cannot be extrapolated for clinical use. 
Future research will be needed to determine validated reference values.
As we have measured PCT in CSF at one point in time only, we do not know at what moment 
after infection peak levels are reached or when PCT levels start to decrease again. This is a highly 
interesting and clinically relevant issue and we are presently performing a follow-up study in 
which daily PCT levels are measured in patients with an external ventricular drain.
Our results show that PCT in CSF could become a useful marker in diagnosing bacterial meningitis. 
This may in particular be the case in patients with suspected meningitis after neurosurgical 
intervention (in contrast to plasma PCT). However, as the PNM group was limited this conclusion 
must be tentative. To our knowledge this is the first article including results of procalcitonin both 
in plasma and in CSF in a varied range of patients groups. An evaluation of PCT CSF:plasma ratios 
in patients with bacterial meningitis has not been done before. A recent study confirmed our 
results in CSF, but plasma levels were not included and therefore a direct comparison of PCT in 
CSF and plasma was lacking [15]. The use of PCT in CSF in determining the need for and possibly 
duration of antibiotic treatment was beyond the scope of this study, but we hope our data will 
open the path to research in that direction. Further research on this subject is needed to assess 
the usefulness of this marker in clinical practice.
We found that PCT is significantly raised in CSF in patients with bacterial meningitis when 
compared to patients with viral or no meningitis. PCT in CSF may become a useful biomarker in 
this patient group and especially in patient after neuro-surgery. 
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Patients with isolated headache may have cerebral venous thrombosis (CVT). D-dimers are 
proven sensitive in excluding deep venous thrombosis (DVT) and pulmonary embolism (PE) in 
low risk patients. We aimed to determine whether D-dimer may play the same role in low risk 
CVT patients with isolated headache.
Methods 
We included consecutive patients suspected of CVT from our teaching hospital with isolated 
headache, a normal neurological examination and normal standard head CT in whom D-dimer 
was determined. Additionally we did a systematic review on articles describing consecutive 
patients suspected of CVT with isolated headache and their D-dimer values. CVT was investigated 
with CT or MR venography in all patients.
Results 
A total of 636 consecutive patients were collected from our own data and the literature search. 
Of 45 CVT patients one had a negative D-dimer (7.5%). Sensitivity of D-dimer for diagnosing 
CVT was 97.8% (95%CI: 88.2%-99.6%), specificity was 84.9% (95%CI: 81.8%-87.7%), positive 
predictive value was 33.1% (95%CI: 25.2%- 41.7%), negative predictive value was 99.8% (95%CI: 
98.9%-100%). Another 56 isolated headache CVT patients were identified in literature, lacking 
consecutive isolated headache controls. Sensitivity of D-dimer for diagnosing CVT including 
these patients was 87.1% (95%CI: 79.0%-93.0%).
Conclusions 
D-dimers have a high negative predictive value in patients with isolated headache for excluding 
CVT. Sensitivity is lower but comparable to the values accepted in PE and DVT. D-dimers in 
combination with a normal neurological examination and normal standard CT may reduce 
unnecessary imaging, making it a potentially valuable marker in low risk patients.
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BACKGROUND
Headache frequently leads to emergency room consultation. It is vital to exclude secondary 
forms of headache requiring further treatment such as cerebral venous thrombosis (CVT). CVT 
is accompanied by headache in 89% of cases [1,2]. It may present with headache alone in 14% 
[3] and acute headache in 3-13% of cases [4-6]. Patients with isolated headache seem to have 
a good prognosis, however, CVT patients with isolated headache who present early (<7 days) 
are more at risk to deteriorate neurologically than patients with isolated headache who present 
later, making diagnosis in an early stage important [6].
D-dimers have been proven useful in the diagnosis of pulmonary embolism (PE) and deep venous 
thrombosis (DVT) [7,8]. Clinical factors are translated to the Wells score, ranking patients to high 
or low risk categories [7]. The Wells score for PE is calculated based on clinical parameters and 
patient history. The score includes clinical signs of DVT, PE being the most likely diagnosis, heart 
rate over 100bpm, recent immobility or surgery, hemoptysis, previous PE or DVT or the presence 
of malignancy , Each item in the Wells score has a rating and patients with 1.5 point or less are 
rated low risk for PE. When low risk Wells score patients have a normal D-dimer, the post-test 
probability of DVT or PE is 0.5-2% when using a sensitive ELISA quantative assay [9]. In these low 
risk patients it is safe to forego further imaging such as echo venography of the lower limbs or 
pulmonary spiral CT. Sensitivity of D-dimer varies from 83-96% in diagnosing DVT patients and 
75-97% in diagnosing PE patients, depending on the performed D-dimer test [10]. 
Whether the measurement of D-dimer can play a similar role in suspected cerebral vein 
thrombosis remains uncertain. A recent meta-analysis of the literature concluded that D-dimer 
may be useful as a diagnostic tool in CVT patients in general, but an analysis for isolated 
headache was not the aim of this review [11]. According to American guidelines patients with a 
high clinical suspicion of CVT should receive neuro-imaging regardless of D-dimer results [12]. 
This makes D-dimer a superfluous test in high risk cases. The definition of low risk patients for 
CVT requires different criteria from the Wells score for PE of DVT. In current practice the presence 
of neurological deficit and abnormalities on standard head CT, but also known risk factors for 
CVT such as pregnancy or use of oral contraceptives are weighed in the decision to perform 
further diagnostic work-up. Whether D-dimers are sensitive enough to exclude CVT in low risk 
patients, without these characteristics and isolated headache is unknown. In these patients 
D-dimer would be valuable to decide whether or not additional imaging is necessary. There are 
conflicting and limited data on patients with isolated headache. One often cited study found 
negative D-dimers in 5 out of 19 (26%) patients with CVT and isolated headache [13]. Another 
prospective study found no false negative D-dimers in 20 patients with isolated headache [14].
We aimed to assess whether D-dimer is a valuable test in CVT patients with isolated headache 
and a low risk of CVT.
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We retrospectively included all consecutive patients with headache who presented to the emer-
gency room of our large teaching hospital from January 2010 to December 2014 with headache 
if a D-dimer was determined at presentation and the presence of CVT was examined with CT 
venography or MRI or both. D-dimers were determined routinely by the treating physician when 
CVT was suspected. As this study was done retrospectively reviewing patient charts, formal 
approval of the local ethics committee was not applicable. We defined isolated headache as 
headache in the absence of abnormalities at neurological examination: lowered consciousness, 
seizures, focal motor deficit, focal sensory deficit, visual field defects, abnormal pupillary 
responses, eye movement disorders, papillary edema and pathological tendon or plantar 
reflexes. We only included patients with normal standard head CT. We felt that in the presence 
of hemor rhage or other abnormalities suspected for CVT at standard CT, follow up diagnostics 
would have been done regardless of D-dimer values. We included patients with known risk 
factors for CVT including oral contraceptive use, pregnancy or in puerperium. 
We recorded headache characteristics including duration and onset, the presence of nausea and 
vomiting and also the number of affected sinuses. Also diagnoses at presentation and after 1 
year of follow-up were recorded. 
D-dimer was determined by the in house laboratory with a Roche second generation latex essay, 
turbidimetric method on a modular chemistry analyzer. D-dimer was deemed negative if lower 
than 0.5 µg/ml. We adopted this cut-off value for CVT also as data differently to this are lacking.
Patients underwent scanning by GE Lightspeed 64 slice CT scanner using intravascular iodine 
contrast. The CT angiography depicted both the arterial and venous system of intra- and extra-
cranial vessels, by scanning the early and late phase of contrast passage. MRA was done with a 
1.5 Tesla Siemens MRI with gadolinium enhanced venography or Time of Flight (TOF) imaging.
Literature search
Literature search for articles was done in Pubmed, and Embase with the following search 
criteria: “cerebral venous thrombosis”, “cerebral venous sinus thrombosis”, “Ddimer”, “D-dimer”, 
“isolated headache” and combinations of these. We also scanned reference lists of found articles 
for possible inclusions. We included original articles focusing on D-dimer determination in 
consecutive patients with suspected CVT, where the presence of isolated headache could be 
determined. Articles were excluded for the meta-analysis if they were reviews or comments. 
Articles were scanned for information on patients with isolated headache. If insufficient data 
were given in the articles, authors were approached for unpublished data on these patients. We 
evaluated the articles with the QUADAS-2 checklist, which is recommended to evaluate the risk 
of bias and applicability of primary diagnostic accuracy studies. [15]
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In these articles data on duration of complaints, risk factors for CVT and headache characteristics 
were also recorded.
Data analysis
Data were evaluated with 2x2 contingency tables and we calculated 95% confidence intervals 
for proportions. Sensitivity, specificity and the negative and positive predictive value could 
be calculated for both our own data and the data extracted from the systematic review. An 
additional calculation of sensitivity was done including patients from literature with established 
CVT that either lacked isolated headache controls or with insufficient information on the control 
group given in the article. As a matched control group was not present for these patients it was 




In our center we found 672 patients who presented to the emergency room with headache in 
whom D-dimer was determined. Of these patients 312 received sufficient imaging to investigate 
the presence of CVT and 149 of these (47.7%) had a normal neurological examination and normal 
standard head CT. Neuro-imaging in these patients consisted of CTA/V in 105, MRI in 23 and both 
modalities in 18 patients (table 1). Average age was 42 years and there were 42 men (28%). Three 
patients had CVT (2.7%) and all had a raised D-dimer. Of the 146 patients without CVT, 63 had a 
raised D-dimer. Sensitivity was 100% (95% CI: 30.5- 100%), specificity 56.8% (95% CI: 48.4-65.0%), 
positive predictive value was 4.55% (95% CI: 1.00-12.7%) and negative predictive value 100% 
(95% CI: 95.6-100%). Average time between symptom onset and diagnosis was 11 days (SD 16) in 
the CVT group and 16 days (SD 88) in the non CVT group. Two patients were pregnant and eight 
had a known use of oral contraceptives.  Two patients using oral contraceptives had CVT and 
both had a raised D-dimer.
Literature search
We identified 118 potentially relevant articles. After excluding duplicates, scanning of titles 
and abstracts 17 articles remained (see figure 1). After further evaluation of these articles we 
found eight articles that described both CVT and non CVT groups with isolated headache and 
their D-dimer levels (table 2). Full information could be immediately extracted from two articles 
[14,16]. In total six authors were approached for additional information. We received additional 
infor mation from one of the approached authors adding information on 173 patients [17]. 
Charac teristics of the included articles were evaluated with the QUADAS-2 (figure 2).
We included 487 patients from the three articles with complete information [14,16,17]. Of 
these patients 42 had CVT (8.6%) of whom one (2.4%) had a negative D-dimer. One patient was 
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Table 1. Characteristics of included patients from our hospital 
CVT + CVT - Total
Patients 3 146 149
Age (mean) 35 42 42














Acute onset of headache 0 62 (41.6%) 62 (41.6%)
Days to presentation median (IQR) 2 (0-8) 3 (1-7) 3 (1-7)
Nausea 3 (100%) 81 (55.5%) 84 (56.4%)
Vomiting 3 (100%) 51 (34.9%) 54 (36.2%)
CTA/V 0 105 (72%) 105 (70.5%)
MRA/V 0 23 (16%) 23 (15.5%)
Both CTA/V en MRA/V 3 (100%) 18 (12%) 21 (14%)
















Legend: CTA CT angiography, CTV CT venography, MRA MR angiography, SAH Subarachnoid hemorrhage, IIH 
idiopathic intracranial hypertension
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Figure 1. Literature search results for articles on patients with isolated headache, with and without CVT and 
D-dimer determination. 
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pregnant and 14 used oral contraceptives. This information was only given for patients with 
established CVT. All patients with these risk factors had a positive D-dimer. There were 445 
patients without CVT, of whom 416 had a negative D-dimer.
Combined data
We included 636 consecutive patients with suspected CVT and normal neurological examination 
from both our data and the collected articles (table 3). In this group 45 had CVT (7.1%) of whom 1 
had a negative D-dimer (1.6%). Sensitivity was 97.8% (95% CI: 88.2%-99.6%), specificity was 84.9 
% (95% CI: 81.8%-87.7%), positive predictive value was 33.1% (95% CI: 25.2%- 41.7%), negative 
predictive value was 99.8% (95% CI: 98.9%-100%) (figure 3). After D-dimer determination there is 
a 0.2% chance of CVT in patients with isolated headache and a negative D-dimer. The prevalence 
of CVT in this group with isolated headache was 7.5%. There is a 6.9% post-test reduction of 
the chance of having CVT in patients with normal neurological examination after D-dimer 
determination.
We also evaluated the articles that included only patients with established CVT [13, 22,23] and 
articles with insufficient data on non-CVT patients [19-21]. From these articles we included 
another 56 CVT patients (table 4). Of the combined 101 patients with CVT and isolated headache 
13 (12.9%) had a false negative D-dimer. D-dimer in this group had a sensitivity of 87.1% (95% 
CI: 79.0%-93.0%).
Figure 2. QUADAS-2 Checklist of three included articles and own methods
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Table 3. Data on 636 patients with isolated headache
CVT No CVT
D-dimer raised D-dimer normal D-dimer raised D-dimer normal
Tardy et al, 2002 6 0 0 17
Kosinski et al, 2004 20 0 27 244
Meng et al. 2014 15 1 2 155
Alons et al, 2015 3 0 63 83
Total 44 1 92 499
Table 4. D-dimer results of CVT patients from articles describing established CVT patients with insufficient data 
on isolated headache in non CVT group.
D-dimer raised D-dimer normal Total (% D-dimer -)
Misra et al, 2009 2 1 3 (33%)
Hiltunen et al, 2013 17 2 19 (10%)
Crassard et al., 2005 14 5 19 (26%)
Gouda, Sabry, 2010 3 3 6 (50%)
Lalive et al, 2003 5 1 6 (17%)
Cucchiara et al, 2005 3 0 3 (0%)
Total 44 12 56 (27%)
Figure 3. Overview of the sensitivity and specificity of the included articles
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In only 33 of the 101 CVT patients information on sinus involvement was available [13,16,19-22]. 
Of these patients 13 had a single affected sinus and D-dimer was negative in 7 cases (54%). In 11 
patients with 2 affected sinuses D-dimer was negative in 4 (36%). In 9 patients with three or more 
affected sinuses none of D-dimers were negative (0%). Information on duration of symptoms 
was available for 42 of 101 CVT patients [16-21]. Seventeen patients had complaints <7 days 
and 6 (35%) of these patients had negative D-dimer. Of the 18 Patients with headache >7 days 5 
(28%) had negative D-dimer. Of the seven patients with headache >14 days 3 (43%) had negative 
D-dimer.
Of the 25 patients who were either pregnant, in puerperium or using oral contraceptives, 17 
had CVT and none had a false negative D-dimer. However data on these risk factors for non-CVT 
controls were not given or could not be reliably deduced in the patients from literature.
DISCUSSION
Our study suggests that D-dimer is a sensitive diagnostic tool in excluding CVT in low risk 
patients. We found a high negative predictive value in patients with isolated headache suspected 
of CVT in our meta-analysis that combined data from our own and three previous series. 
This is comparable with the values found in PE and DVT when a low risk Wells score, based 
on physical examination, is combined with negative D-dimer. Our meta-analysis describes the 
largest group of patients with isolated headache studied for the diagnostic value of D-dimer in 
recent literature. This is also the only study focusing on low risk CVT patients, making the results 
valuable for everyday practice.
Our study has limitations. First, insufficient data on isolated headache and concomitant D-dimer 
levels were available from six potential useful articles [13, 17, 19, 21-23]. We attempted to 
obtain additional information from the concerned authors but received information from only 
one [17]. However, we did collect data on a large number of patients allowing a sufficiently 
precise estimation of the diagnostic value of D-dimer in this low risk group. Second, we could not 
determine how many headache patients presented to our hospital in whom D-dimer was not 
determined in this period. Unfortunately, it is not possible to reliably retrieve this information 
from the hospital information system. This means that in our evaluation very low risk patients 
may have been missed compromising the generalizability of the findings. On the other hand, 
the addition of patients from studies performed in other large hospitals in several countries 
improved the generalizability of our results..
Finally, the D-dimer determination method varied over the cited articles; however, most articles 
used quantitative latex assays, with high sensitivity with the same cut-off value. It was not 
possible to calculate D-dimer cut-off levels in this group as exact values were not given in most 
articles, in particular not in patients without CVT.
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We defined patients to have a low risk of CVT when they had a normal neurological examina-
tion and normal standard head CT. The definition of a normal neurological examination might 
be a point of discussion as papillary edema for instance may be difficult to determine reliably 
and in many cases is not judged by the treating physician at all. In an earlier study patients 
with papillary edema were included in a cohort with isolated headache [6]. In our group two 
patients with papillary edema alone had a negative D-dimer, and were excluded from our group 
of patients with isolated headache. Also a symptom like tinnitus which may be present in raised 
intra cranial pressure is often not mentioned and could not be included in our definition.
A raised risk of CVT exists during pregnancy and puerperium and in patients using oral contra-
ceptives, but also in older patients and patients with underlying malignancy. These patients are 
also at risk of having a false positive D-dimer. In the entire group three patients were reported to 
be pregnant and 22 were reported to be using contraceptives.  However, the use of contraceptives 
or presence of pregnancy in the patients from literature could only be clearly deduced in those 
with established CVT. The limited number of patients and insufficient reporting of pregnancy 
and use of contraceptives makes it difficult to give recommendations. Caution in this high risk 
group seems warranted and we feel these patients should undergo follow up neuro-imaging 
when CVT is suspected regardless of D-dimer outcome. Of all consecutive patients with CVT 
there were 1.6% false negative D-dimers. Earlier concerns regarding usability of D-dimer in this 
patient group was based on percentages found in studies citing percentages of false negative 
D-dimers ranging from 10-50% [12, 15, 19, 20-22]. However these articles did not mention 
D-dimer results in non-CVT patients or gave insufficient data on this control group. In our own 
patient group no false negative D-dimers were found, which was confirmed by three studies, 
including two large prospective studies [11,17,18]. Including these articles in our meta-analysis, 
the sensitivity of D-dimer in isolated headache patients for detection of CVT is 87% (95% CI: 
79.0%-93.0%). This sensitivity is lower, but comparable to, sensitivity found in various tests used 
for D-dimer determination in PE and DVT patients [10]. Unfortunately as no matched isolated 
headache controls are described, the calculation of specificity and the negative and positive 
predictive value for this entire group is impossible. As the patients in most of these articles were 
collected over time in tertiary headache referral centers, they may cause an overestimation of 
CVT, with large numbers of controls balancing them out.
When evaluating the risk for false negative D-dimer this is higher in patients with a single affected 
sinus and patients with a longer duration of complaints [14]. Unfortunately information on both 
these parameters was only available in a small number of patients and conclusions on these 
factors cannot be drawn from our data. These parameters are an important focus of future 
prospective research.
In patients with isolated headache D-dimer could become a useful screening tool to exclude 
CVT and may help reduce unnecessary additional imaging using intra-venous contrast or MRI. In 
the presence of risk factors for CVT such as pregnancy, puerperium, use of oral contraceptives, 
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neurological symptoms and abnormalities on standard head CT it remains necessary to perform 
diagnostic follow-up. As is the case in DVT and PE D-dimers cannot be seen a stand-alone test 
and must be combined with clinical risk factors. The high negative predictive value of 99.8% may 
aid the physician in decision making, although a positive result does not prove the presence 
of CVT due to low positive predictive value. Although sensitivity is lower, it is comparable to 
sensitivity accepted in excluding PE and DVT. In this series the use of negative D-dimer would 
have avoided additional neuro-imaging for diagnosing CVT in 502 patients, whereas only 89 
patients with false positive D-dimer would have been scanned unnecessarily. One patient would 
have been missed. Prospective studies confirming our findings concerning low risk CVT patients 
are needed.
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In this thesis several diagnostic tests have been evaluated ranging from CSF testing to neuro-
imaging to D-dimer testing in serum in patients who present to the emergency room with 
headache. 
NON CONTRAST CT AND CT-ANGIOGRAPHY
Whether or not to perform additional imaging in patients with acute headache has been under 
much debate. The main arguments against performing a CTA have been based on follow-up 
studies combined in a pooled analysis, which showed that morbidity after excluding SAH (either 
with NCCT < 6h or an LP without signs of hemorrhage) was very low [1]. However follow-up in the 
included studies was limited and did not focus on CVT, (viral) meningitis, arterial dissections or 
RCVS. In fact, none of these conditions was diagnosed. A surprising finding, which seems highly 
unlikely considering the expected prevalence of these conditions in this population.
CVT may present with acute severe headache, without neurological deficit in 3-13% of cases 
[2,3]. Cervical arterial dissection has been reported to present with acute headache as the only 
symptom in 20% of cases [4,5]. RCVS has been reported to present with isolated headache in 
57% to 88% of cases [6]. 
In our study addressing bilirubin detection (chapter 5) we found a surprisingly large number of 
patients with a vascular abnormality on CTA with a normal neurological examination and normal 
NCCT (19%). A comparable study found 6.6% vascular abnormalities in a group of patients with 
acute headache, normal neurological examination and normal NCCT [7]. The number of detected 
abnormalities in both studies was higher than might be expected in the general population, but 
the variation between two percentages was high. This inspired us to perform further studies to 
determine whether after a normal NCCT the search for a cause of acute headache is really over. 
We found a lower percentage of vascular abnormalities in our meta-analysis in patients with 
acute headache, a normal neurological examination and normal NCCT of 7.4%. In this study 
we attempted to improve generalizability by combining a retrospective group from the Leiden 
University Medical Center and Haaglanden MC with patients from literature. The majority of 
abnormalities consisted of aneurysms. It is unclear whether these aneurysms had ruptured or 
were incidental findings without clinical relevance. Not all patients received lumbar punctures 
and therefore we could not determine if the aneurysms had bled. If an aneurysm has not bled 
the need for treatment is determined by its location and size and patient related factors such 
as age and hypertension [8]. In some case reports inflammation of an aneurysm or sudden 
distension has been named as a possible cause of acute headache [9-12]. Generally it seems 
more likely that unruptured intracranial aneurysms (UIA) are not the cause of acute headache 
but must be deemed a co-incidental finding. In our first retrospective study we found eight 
aneurysms, all unruptured since the LP did not show any signs of hemorrhage. Of these eight 
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aneurysms six were either coiled or clipped. The reason for this was not always clear, but four 
were large, with a size of or over 7 mm. As other aneurysms were left untreated they may give 
rise to much fear and insecurity in the patient. The need for medical follow-up and radiation 
due to excess scanning imposes an additional burden. The finding of the aneurysm may have 
lowered the quality of life of these patients.
Finally we also found abnormalities that were definitely clinically relevant. These consisted of 
diagnoses such as CVT, RCVS and arterial dissections. However the number of definitely clinically 
relevant abnormalities was only 1.6%. How to detect those, but avoid making unnecessary CTA’s?
In chapter 4 we attempted to construct a prediction model to determine clinically relevant findings 
on CTA in patients with acute severe headache. We found that the presence of an abnormal 
NCCT is the strongest predictor for finding an abnormality on CTA. When other significantly 
predicting factors such as ongoing lowered consciousness and subjective neurological deficits 
were included in a combination prediction model, it did not significantly increase the AUC. 
For clinical practice this seems an open door, as an abnormality on NCCT will directly warrant 
additional imaging either in the form of CTA or MRI/MRA, but it is disappointing that other 
patient characteristics did not have additional predictive value.
We were more interested in clinical factors predicting abnormalities in patients with a normal 
NCCT. In this group the decision to perform additional imaging is more challenging and evidence 
when to perform a CTA or MRI is unavailable. Diagnostic yield in this group was low however 
(3.6%). In fact the yield was so low that isolated clinical predictors in patients with a normal NCCT 
could not be determined.
The variation in the prevalence of abnormalities we found in our studies is striking and may 
be due to several potential biases. In the group with 19% abnormalities (acute headache, 
normal neurological examination, normal NCCT and normal LP) all patients received a lumbar 
puncture without signs of hemorrhage. The patients were included retrospectively from a time 
when protocol mandated a lumbar puncture for all patients with acute headache even if non-
contrast CT was normal within 6 hours of presentation. The lumbar puncture is considered to 
be pain- and stressful for patients as well as time consuming. Due to these restraining factors 
the selection of patients may have been stricter with exclusion of cases with doubtful headache 
onset or clinical symptoms. Also, as this was a retrospective study there may have been an 
indication bias for performing the CTA. The patients in this series also had a high recurrence rate 
of vascular abnormalities raising the number of abnormalities. It seems likely that these patient 
related factors such as previous SAH or CVT were selection factors to perform a CTA. 
All in all the high prevalence of 19% vascular findings found in the first, retrospective study, 
could not be reproduced in our cohort studies that followed and so, also in relation to literature, 
seems an unlikely high number. It seems more likely that the number of clinically relevant 
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abnormalities is around the 1.6-1.8%, which we found in our meta-analysis and prediction 
model [13,14]. Although few, the severity of the detected abnormalities makes it hard to advise 
against CTA in this group. Currently a prospective study in patients with acute headache, normal 
neurological examination and normal NCCT is ongoing with the aim to determine a more precise 
estimate of the prevalence of abnormalities in this group and potential patient factors related to 
the finding of a vascular cause for the acute headache. Thus, we hope to be able to find a way 
to purposefully apply the CTA with a high yield of diagnoses or be able to prove that it can be 
foregone altogether and reduce diagnostic burden and costs.
Cerebral spinal fluid
Bilirubin
In chapter 5 we evaluated two methods of photospectometry for the determination of bili-
rubin in cerebrospinal fluid (CSF) in patients with acute severe headache. Photospectometry 
is, surprisingly, not yet ubiquitous as a determination method for bilirubin in CSF. In the United 
States visual inspection is still widely used with a sensitivity of only 47.3% [15].
The determination of bilirubin remains important in patients who present more than six hours 
after their acute headache. These patients require CSF testing to exclude SAH. Furthermore, if 
an aneurysm is found it is important to determine whether it is a ruptured aneurysm, because 
this is an important factor which determines the need for treatment. We compared the UK 
NEQAS method with the Leiden method in 391 patients. The Leiden method is a calculation 
model which evaluates the presence of blood pigments at set absorption values and thus 
calculates the concentrations of bilirubin, methemoglobin and oxyhemoglobin. The UK NEQAS 
ads a decision tree after photospectometry. In both methods the sensitivity for identifying an 
aneurysm after a positive test result was 100%. However, with the Leiden method specificity 
was lower. Confounders in the Leiden method were viral and bacterial meningitis and cerebral 
venous thrombosis. The UK NEQAS has a more conservative cut-off value also resulting in more 
negative results. This did not affect sensitivity. The down side of the UK NEQAS method is that 
it requires additional evaluation from either an experienced laboratory technician or clinical 
chemist. We advise the use of the UK NEQAS method only on CSF results suspected of SAH with 
the Leiden method in order to optimize work flow.
Procalcitonin
In chapter 6 we described a prospective study, which evaluated the production of intrathecal 
procalcitonin in patients suspected of bacterial and viral meningitis. Two previous studies showed 
significantly higher PCT concentrations in CSF in patients with bacterial meningitis compared with 
tick-borne encephalitis or viral meningitis [16,17]. We included a varied population of patients 
with both community acquired bacterial meningitis and bacterial meningitis after neurosurgical 
intervention. We found that procalcitonin in CSF was significantly raised in patients with bacterial 
meningitis compared with patients without bacterial or viral meningitis. In patients after neuro-
surgical intervention the PCT in CSF was raised relatively more than in plasma suggesting a direct 
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port of entry of infection. Particularly after surgery the spillage of plasma in CSF may give rise to 
confusing findings in conventional CSF chemistry. Even when corrected for erythrocyte numbers 
the PCT CSF:plasma ratio was still higher in patients with post neurosurgical bacterial meningitis.
A limitation of this study was its limited size. Second, we could not prove all bacterial meningitis 
cases with a positive culture. To improve the specificity we applied specific CSF chemistry criteria 
for the diagnosis of bacterial and viral meningitis.
Despite the small number of patients we feel PCT may be of interest as a valuable diagnostic 
marker to differentiate bacterial meningitis from aseptic meningitis, particularly in patients who 
had a neurosurgical intervention. 
D-dimer in serum
In chapter 7 we presented a meta-analysis evaluating the diagnostic characteristics of D-dimers in 
patients, which were suspected of cerebral venous thrombosis (CVT) with a normal neurological 
examination and normal non-contrast head CT. In these low risk patients a normal D-dimer may 
aid the decision whether CT venography is necessary or not. There are conflicting and limited 
data on patients with isolated headache. One often cited study found negative D-dimers in 5 out 
of 19 (26%) patients with CVT and isolated headache [18]. Another, prospective, study found no 
false negative D-dimers in 20 patients with isolated headache [19]. 
In our study, we found D-dimers have a high negative predictive value in patients with isolated 
headache for excluding CVT of 99.8%. Sensitivity is lower but comparable to the values accepted 
in PE and DVT. Low risk patients were defined as headache patients with a normal neurological 
examination, normal standard head CT and absence of risk factors such as pregnancy or 
puerperium. Normal D-dimers in these patients may reduce unnecessary imaging, making it 
a potential valuable marker. In patients with additional risk factors such as pregnancy or the 
use of oral anti-contraceptives additional imaging is still necessary and Ddimer is insufficient to 
exclude CVT.
Our study had some limitations. First, patients were included retrospectively. Second, varying 
methods of D-dimer determination made it impossible to determine a D-dimer cut-off value 
or diagnostic area under the curve. Furthermore, due to missing data on control patients with 
isolated headache we could not calculate negative and positive predictive values for the entire 
available population. However, our meta-analysis is the only one focusing on such a large group 
of patients with isolated headache suspected of CVT. The population is multi-centered and 
international, improving generalizability. 
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In patients with acute headache who present to the emergency room the yield of a CTA is highest 
in patients with an abnormality on head NCCT. The yield in patients with normal NCCT is low. 
A multivariable prediction model showed that clinical symptoms have no added value over the 
variable ‘normal NCCT’ alone. In patients with acute headache and a normal NCCT the yield of CTA 
is higher than in the general population, but findings consist mainly of unruptured intracranial 
aneurysms that do not always have treatment implications and may generate anxiety. The 
sporadically found cervical dissection, CVT or RCVS may justify performing CTA. At the moment 
there are no clinical factors, which can predict which patients will have an abnormality on CTA 
after a normal NCCT.
In patients who are suspected of CVT but who have no additional risk factors besides headache, 
CT venography is unnecessary if the D-dimer level in serum is normal. The negative predictive 
value of D-dimer in this group is very high for excluding CVT. 
If CSF testing for the presence of bilirubin is required, the Leiden method, an iterative calculation 
model, is 100% sensitive. Specificity can be increased if the UK NEQAS method is applied on the 
CSF’s that test positive with the Leiden method. This workflow assures both highest specificity 
and highest laboratory workforce efficiency. 
In patients suspected of bacterial meningitis procalcitonin determination in CSF may become a 
valuable marker particularly in patients with confounding factors such as recent neurosurgical 
intervention. The differentiation from aseptic or septic meningitis in this group is difficult and an 
additional marker would be valuable to avoid unnecessary antibiotic treatment.
FUTURE PERSPECTIVES 
Whether a CTA/CTV is needed in all patients with sudden severe headache is still unknown. 
A prospective study is needed to evaluate which patients need to be selected for CTA/CTV or 
whether it can be foregone altogether. We recently started a prospective study performing CTA 
in all patients with acute headache, normal neurological examination and normal non-contrast 
head CT. This study is carried out in a multi-center setting in the Haaglanden MC and Leiden 
University Medical Center. We hope to ascertain the yield of CTA in this patient group and pos-
sibly define patient characteristics that may aid in the decision whether or not to perform a CTA.
The prognosis of patients who presented the emergency room with acute headache in terms 
of long-term diagnosis, recurrent episodes of headache and quality of life is unknown. A follow-
up study evaluating this is being started in the MCH and the LUMC. We aim to contact patients 
who presented in the past 4 years with acute headache to our emergency departments and will 
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perform a standardized questionnaire concerning possible new episodes of acute headache and 
long-term diagnosis. A secondary outcome measure will be how the patient experienced the 
initial emergency room visit; was the final diagnosis clear? Were they sufficiently put at ease? Did 
they receive expected tests?
A further prospective study is needed to evaluate the sensitivity and specificity of D-Dimer in 
patients suspected of CVT. However, this is a challenging study since CVT needs to be suffi ciently 
excluded in order to be able to make conclusions.
Finally, more research on the use and sensitivity of determining procalcitonin in CSF is needed 
to evaluate the role of procalcitonin as a biomarker for bacterial meningitis. Particularly the 
dynamics of procalcitonin levels during the presence of an external ventricular drain (EVD) is 
of interest. A prospective study is being set up in our center in which daily determination of 
PCT will be performed in patients with an EVD in relation to daily CSF cultures to further assess 
diagnostic sensitivity and specificity.
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Headache is a common problem and a frequent reason for presentation at the emergency 
department. For the treating physician the challenge lies in separating the innocent, albeit 
painful, primary headaches (migraine, cluster headache, tension type headache) from the 
secondary headaches with high morbidity and mortality such as subarachnoid hemorrhage, 
cerebral venous thrombosis, reversible cerebral vasoconstriction syndrome, cervical arterial 
dissection or meningitis.
This thesis focuses on a variety of diagnostic tests, which are used to identify these different 
types of headache. The aim is not only to evaluate the diagnostic yield of these tests, but also 
when to apply them in which patients. A large part of this thesis is dedicated to the diagnostic 
yield of CTA in patients presenting to the emergency department with headache. In patients with 
acute headache and a normal non-contrast cerebral CT (NCCT) we found a higher number of 
abnormalities than may be expected in the general population. In our first study on this subject 
we found 13 (19%) vascular abnormalities in 70 patients (Chapter 2). In this group a considerable 
number of patients had previous neuro-vascular episodes such as a SAH or CVT. Furthermore, 
these patients were included based on a lumbar puncture without signs of hemorrhage. 
This was in the period before a groundbreaking study proved from Canada that if a NCCT is 
performed within 6 hours after the start of headache, a lumbar puncture is no longer needed to 
exclude SAH. This means that a selection bias may exist for these patients as a lumbar puncture 
is considered to be pain- and stressful and would only have been performed in patients with 
definite acute headache. 
In our follow-up study (Chapter 3) we combined a more recent population of patients with 
acute headache who received a CTA in a series from the LUMC and Haaglanden MC with those 
described in literature in a meta-analysis and found a vascular abnormality in 7% of patients. 
Most of these abnormalities consisted of aneurysms of which the clinical relevance could not be 
clarified. In the general population an aneurysm can be found in 2-3%, in this group we found a 
prevalence of 5.4% aneurysms. We could not elucidate how many of these aneurysms had bled 
or not. Therefore we could not determine which percentage of aneurysms was causative of the 
acute headache and how many were incidental findings, i.e. unruptured intracranial aneurysms. 
In a small number of patients we found a definite clinically relevant abnormality such as cerebral 
venous thrombosis (three cases; 0.5%), revisable cerebral vasoconstriction syndrome (four 
cases; 0.5%), Moya moya (two cases; 0.3%), cervical arterial dissection (two cases; 0.3%) and 
ischemia (one case; 0.1%). The number of patients needed to scan to find one abnormality was 
14 and the number needed to scan to find a definite clinically relevant abnormality was 61. Thus 
it seems that the number of clinically relevant findings on CTA in patients with acute headache, 
a normal neurological examination and normal NCCT is low. This correlates with findings of 
earlier follow up studies that showed that morbidity in this group is low. However, the clinically 
relevant abnormalities did warrant medication change and intensified follow-up. Therefore it 
519320-L-bw-Alons
Processed on: 2-5-2018 PDF page: 109
109
English summary
seems unwise to definitely advise against CTA altogether, but the purposeful use of CTA does 
become important. If it were possible to identify patients for CTA with a high diagnostic yield we 
could minimize the number of scans but still identify patients that need additional treatment. 
Therefore, we proceeded to construct a prediction model for identifying vascular abnormalities 
with CTA in patient with acute headache.
We found, unsurprisingly, that an abnormality in NCCT is the strongest predictor for identifying 
an abnormality on CTA (Chapter 4). Other factors that contributed significantly to finding 
an abnormality were ongoing lowered consciousness and abnormalities at neurological 
examination. But the combination of these factors gave no better diagnostic characteristic than 
an abnormal NCCT alone. These findings are somewhat of an open door in clinical practice as any 
of these clinical findings would prompt follow-up imaging in any case. We were most interested 
in patients with normal NCCT as in this group the decision whether or not to perform additional 
imaging is less clear. We found a very small number of clinically relevant vascular abnormalities 
that warranted treatment. We could not identify clinical factors for the performance of CTA. A 
prospective study to identify selection criteria for CTA in patients with acute headache, normal 
neurological examination and normal NCCT is now being performed.
In some cases testing of cerebrospinal fluid for hemorrhage is still necessary. We compared two 
workflows for evaluating bilirubin, a blood breakdown product that is found in patients after 
subarachnoid hemorrhage, in cerebrospinal fluid (chapter 5).
The Leiden method is a calculation model used in combination with photospectometry testing 
of CSF and is 100% sensitive. In photospectometry the wavelength of various blood breakdown 
products is used to determine their presence in cerebrospinal fluid. Specificity of the Leiden 
method is lowered if the cerebrospinal fluid contains a lot of protein or if patients have high 
serum bilirubin. The specificity can be increased if the UK NEQAS method is applied on the 
cerebrospinal fluid samples that test positive with the Leiden method. This requires additional 
evaluating using a decision tree by the local clinical chemist. This workflow assures both highest 
specificity and highest laboratory workforce efficiency.
Sometimes it may be possible to avoid additional imaging. In patients suspected of CVT additional 
CT venography (CTV) or MRI is often performed to evaluate this possibly fatal condition. D-dimer 
is a protein involved in the thrombotic chain and is often determined in patients suspected of 
pulmonary embolism (PE) or deep venous thrombosis (DVT). In patients with a low risk of PE or 
DVT based on clinical criteria and with a normal D-dimer do not need additional imaging e to the 
very low risk of thrombosis. In this thesis a meta-analysis was performed to evaluate whether 
CTV may be avoided in patients with a low risk of CVT (isolated headache) and a normal D-dimer 
(Chapter 7). In a group of 636 patients we found 45 patients with CVT. Of these 45 patients one 
had a false negative D-dimer. Sensitivity of D-dimer for detecting CVT in patients with isolated 
headache was 97.8% (95% CI: 88.2-99.6 %), specificity was 84.9% (95 % CI: 81.8-87.7%), the 
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positive predictive value was 33.1% (95% CI: 25.2-41.7%) and negative predictive value was 99.8% 
(95% CI: 98.9-100%). D-dimer can be used to avoid additional imaging in low risk CVT patients.
Finally we studied intrathecal procalcitonin production in patients with a suspicion of bacterial 
meningitis (chapter 6). Procalcitonin is an acute phase protein which is released in the serum 
during bacterial infection. In serum it has been proven to discriminate between bacterial and 
viral infections, or auto-immune responses. In the cerebrospinal fluid (CSF) procalcitonin is 
also present and most likely produced by glia cells. In our study we showed that procalcitonin 
is significantly raised in patients with bacterial meningitis in comparison with patients with 
viral meningitis or acute headache. Furthermore, in patients after neurosurgical intervention 
procalcitonin is relatively more raised in CSF than in serum. This skewed distribution seems to 
indicate a direct port of entry rather than a raised value due to for instance a traumatic puncture. 
All in all procalcitonin seems a promising diagnostic marker in suspected meningitis. 
We have started several follow-up studies concerning the subjects discussed here. A prospective 
multi-center study is ongoing to evaluate the diagnostic yield of CTA in patients with acute 
headache, normal neurological examination and a normal NCCT. Also a follow-up study on the 
recurrence rate of episodes of acute headache has been started.
Finally a clinical study evaluating the day to day of procalcitonin in cerebrospinal fluid in patients 
with an external ventricular drain is being performed.
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Hoofdpijn is een veel voorkomende klacht waarmee patiënten zich op de spoedeisende hulp 
pre senteren. De taak van de neuroloog bestaat eruit de onschuldige, maar vaak zeer belas tende, 
primaire hoofdpijnen (bijv. migraine, clusterhoofdpijn en tension type hoofdpijn) te onder-
scheiden van de mogelijke fatale secundaire hoofdpijnen zoals subarachnoïdale bloeding (SAB), 
cerebraal veneuze trombose (CVT), reversibel cerebraal vasoconstrictie syndroom, dissectie 
of meningitis.
Dit proefschrift richt zich op verschillende diagnostische onderzoeken om de oorzaken van deze 
typen hoofdpijn vast te stellen. Het doel is niet alleen het evalueren van de onderzoeken zelf, 
maar ook wanneer en bij welke patiënten het onderzoek in te zetten. 
Een groot deel van dit proefschrift is gewijd aan het beoordelen van de opbrengst van de CT 
angio grafie bij verschillende groepen patiënten met hoofdpijn op de spoedeisende hulp. Bij 
patiën ten met acute hoofdpijn en een normaal neurologisch onderzoek en normale blanco CT 
scan van de hersenen lijkt er een licht verhoogd aantal afwijkingen te worden gevonden. In ons 
eerste onderzoek naar dit onderwerp vonden wij bij 13 (19%) van 70 patiënten een afwijking 
(hoofd stuk 2). Een aanzienlijk deel van deze patiënten had een neuro-vasculaire episode door-
gemaakt zoals een eerdere SAB of CVT. Verder waren deze patiënten geïncludeerd op basis 
van een verrichte ruggenprik met normale uitkomst. Dit was in de periode voordat onderzoek 
uitwees dat indien binnen 6 uur van het ontstaan van de hoofdpijn er een blanco CT is verricht, 
er geen ruggenprik meer hoeft te gebeuren. Hierdoor is mogelijk al een strengere selectie van 
patiënten opgetreden, omdat een ruggenprik een belastend onderzoek is.
Ons volgende onderzoek was gebaseerd op een recentere populatie uit zowel het Leids Univer-
sitair Medisch Centrum als het Haaglanden Medisch Centrum en verder op patiënten uit de 
literatuur. In de meta-analyse, vonden wij een afwijking bij 7% van de patiënten (hoofdstuk 3). De 
meeste afwijkingen betroffen aneurysmata waarvan de klinische betekenis niet geheel duidelijk 
is. Ongeveer 2-3% van de bevolking heeft een intracranieel aneurysma; wij vonden een aneurysma 
bij 5.4% van de patiënten. Het was in de onderzoeksgroep niet goed te achterhalen bij hoeveel 
van de gevonden aneurysmata er een bloeding optrad, aangezien niet in alle gevallen bekend 
was of er bilirubine in het hersenvocht werd bepaald. Dit is relevant om te achterhalen of het 
een niet gebarsten aneurysma, dat is een toevalsbevinding, betreft. In een klein aantal gevallen 
werd een zekere klinisch relevante bevinding gedaan. Wij stelden een trombose van de venen 
van de hersenen vast bij drie patiënten (0.5%), een reversibel vasoconstrictie syndroom bij vier 
patiënten (0.5%), een Moya-Moya bij twee patiënten (0.3%), een arteriële dissectie bij twee (0.3%) 
en een herseninfarct bij één patiënt (0.1%). Het aantal patiënten dat gescand moest worden om 
enigerlei afwijking te vinden was 14 en het aantal om een klinisch relevante afwijking te vinden 
was 61. Het lijkt erop dat het aantal gevonden klinisch relevante afwijkingen bij patiënten met 
acute hoofdpijn en normale bevindingen bij neurologisch onderzoek en blanco CT klein is. Dit 
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komt overeen met het eerder vastgestelde gunstige beloop bij deze groep bij follow-up studies. 
De afwijkingen welke wél worden gevonden zijn echter bedreigend en vereisten het geven van 
medicatie of intensievere follow-up. Daarom is het definitief ontraden van een CTA bij deze 
groep een brug te ver. Een prospectieve studie om de diagnostische opbrengst te beoordelen 
loopt momenteel in het Leids Universitair Medisch Centrum en Haaglanden Medisch Centrum.
Naast de patiënten met een normaal neurologisch onderzoek en normale blanco CT scan hebben 
we ook gekeken naar factoren die het vinden van afwijkingen op CTA beïnvloeden bij patiënten 
met acute hoofdpijn in het algemeen die zich op de spoedeisende hulp presenteren (hoofdstuk 
4). Het blijkt dat verschillende factoren hierbij mee spelen, maar een afwijkende blanco CT alleen 
is al zo’n sterke voorspeller dat het toevoegen van andere voorspellende factoren de waarde van 
de blanco CT niet overtreft.  Hoewel dit nogal een open deur lijkt, is het goed om te weten dat de 
kans om een afwijking te vinden bij een normale blanco CT zeer klein is. We vonden nog wel een 
klein aantal afwijkingen dat wel verdere behandeling behoefde.
Bij sommige patiënten is het toch nodig om het hersenvocht te onderzoeken op tekenen van een 
doorgemaakte bloeding. Dit kan door het bepalen van de aanwezigheid van bloedafbraakpro-
ducten, zoals bilirubine met fotospectometrie. Hierbij wordt de bekende resonantiegolflengte 
van de bloedafbraakproducten gebruikt om de aanwezigheid ervan in het hersenvocht te be-
palen. Wij vergeleken twee methoden om deze bepaling te beoordelen (hoofdstuk 5). De Leiden 
methode is een rekenmethode gebruikt in combinatie met fotospectometrie en deze heeft een 
sensi tiviteit van 100%. De specificiteit wordt echter verlaagd als er veel eiwit in het hersenvocht 
aanwezig is of als een patient veel bilirubine in het bloed heeft. De specificiteit kan verbeterd 
worden door het toepassen van de UK NEQAS methode indien de Leiden methode afwijkingen 
toont. Bij de UK NEQAS wordt een aanvullende beoordeling door de klinisch chemicus verricht 
met een beslisboom. Door de twee methoden in deze volgorde te gebruiken kan een maximale 
sensitiviteit en specificiteit worden bereikt zonder dat er een overmatige werkbelasting ontstaat.
In bepaalde gevallen zou het ook mogelijk kunnen zijn om aanvullende beeldvorming te voor-
komen. Bij patiënten met een verdenking op trombose van de afvoerende hersenvaten of 
venen, wordt frequent aanvullend CT venografie of MRI verricht om dit uit te sluiten danwel 
aan te tonen. D-dimeer is een stollingseiwit dat wordt bepaald bij de diagnostiek rondom 
longembolieën en diep veneuze trombose. Bij patiënten met een op klinisch bepaalde gronden 
laag risico op diep veneuze trombose en longembolieën en een normaal D-dimeer is uit 
eerder onderzoek gebleken dat het niet nodig is aanvullende beeldvorming te verrichten. In dit 
proefschrift is onderzocht of bij patiënten met een laag risico op cerebrale veneuze trombose 
beeldvorming vermeden kan worden bij een normaal D-dimeer (hoofdstuk 7). In een groep 
van 636 patiënten hadden er 45 een cerebrale veneuze trombose. Daarvan had er één een 
fout negatieve D-dimeer (7.5 %). De sensitiviteit van D-dimeer voor het stellen van de diagnose 
cerebrale veneuze trombose was  97.8 % (95 % betrouwbaarheidsinterval(BI): 88.2-99.6 %), de 
specificiteit 84.9 % (95 % BI: 81.8-87.7 %), de positief voorspellende waarde 33.1 % (95 % BI: 25.2-
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41.7 %) en de negatief voorspellende waarde 99.8 % (95 % BI: 98.9-100%). Het bepalen van een 
D-dimeer kan worden gebruikt om aanvullende beeldvorming te vermijden bij patiënten met 
een laag risico op cerebraal veneuze trombose . 
Als laatste hebben wij gekeken naar de productie van procalcitonine in het hersenvocht, bij 
patiënten met de verdenking op een bacteriële meningitis. Procalcitonine is een acute fase eiwit 
dat wordt aangemaakt bij bacteriële ontstekingen. In serum is aangetoond dat hiermee onder-
scheid gemaakt kan worden tussen septische of aseptische ontstekingsreacties. In hersen vocht 
wordt procalcitonine waarschijnlijk aangemaakt door gliacellen. In ons prospectieve onderzoek 
toonden wij aan dat procalcitonine significant verhoogd is bij patiënten met een bacteriële 
meningitis ten opzichte van patiënten met acute hoofdpijn of een virale meningitis (hoofdstuk 
6). Verder is bij patiënten met een bacteriële meningitis na een neuro chirurgische interventie de 
procalcitonine spiegel relatief veel sterker verhoogd in de liquor dan in het serum. Deze scheve 
verdeling lijkt erop te duiden dat procalcitonine in de hersenen of hersenvliezen zelf word aan-
ge maakt in plaats van bijvoorbeeld door bloedbijmenging rondom de liquorpunctie. Al met al lijkt 
procalcitonine een veelbelovende marker te zijn rondom de diagnostiek van bacteriële meningitis.
Naar aanleiding van de hier besproken onderzoeken zij nu meerdere studies gaande. Een pros-
pectief multicenter onderzoek is bezig waarbij de opbrengst van CT angiografie bij patiënten 
met acute hoofdpijn, een normaal neurologisch onderzoek en een normale blanco CT wordt 
bekeken. Ook zal worden gekeken naar het opnieuw optreden van episoden met acute hoofdpijn 
in onze retrospectieve patiënten groep. Als laatste loopt op dit moment een onderzoek naar de 
hoogte van het procalcitonine van dag tot dag bij patiënten met een externe ventrikel drain na 
een doorgemaakte bloeding.
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In de tijd dat ik aan dit proefschrift werkte ben ik door meerdere mensen geholpen. Zowel op 
weten schappelijk vlak als meer persoonlijk. Beide aspecten zijn van groot belang geweest om 
het werk te voltooien en daarom wil ik deze mensen bij dezen bedanken voor hun hulp en 
goede zorgen.
Allereerst prof. Algra, beste Ale; door mijn woonomstandigheden hadden wij veel contact 
via de mail en maar weinig van persoon tot persoon, maar dit is voor mijn gevoel nooit een 
belem mering geweest en het contact was snel, vriendelijk en precies. Je goede adviezen en ver-
beteringen, met vaak een grapje in de kantlijn van de toegestuurde PDF’s,  waren altijd op zijn 
plaats en waardevol en zonder je uitgebreide ondersteuning ten aanzien van de statistiek was 
het me nooit gelukt alles af te krijgen.
Beste Korné, met de gevleugelde woorden: “nu hebben we alleen nog een hoogleraar en een 
stuk of drie artikelen nodig” leek de promotie als het ware voor het grijpen, deze houding van 
actie en aanpakken tekent je. Je snelle en concrete reacties en adviezen zijn zeer waardevol 
geweest, naast je begrip voor het drukke gezinsleven.
Beste Marieke, jij haalde altijd nét weer even wat andere dingen uit de stukken die aangepast 
of verbeterd moesten worden en de doelstellingen van de onderzoeken werden klinisch 
relevanter doordat jij goed aangaf welke lijn nu echt het meest zinnig was. Je adviezen waren 
goed doordacht en praktisch, dank voor het fijne contact.
Beste Rolf, jij bent vanaf het begin van mijn onderzoek een steun geweest en een fijne collega 
doordat je ingewikkelde lab ‘dingen’ goed helder kon maken voor mijn niet zo scheikundig 
ingestelde brein. Het was fijn samenwerken, wat ik niet als enige vond, ook de ogen van je 
collega-AIOS uit den landen lichten een beetje op als je ter sprake kwam.
Ben, jij hebt veel uren gestoken in onze database. Dank voor je hulp en meedenken met de 
manuscripten.
Marianne, Gabrielle en Irma, hartelijk dank voor jullie vaktechnische en goede adviezen rondom 
de door jullie gesuperviseerde studies.
Verder wil ik mijn collega AIOS in het Westeinde bedanken. In het speciaal Rachel, Mirjam, Anouk 
en Moniek. De tijd met jullie op de KNF en daarbuiten was ontzettend fijn en gezellig. Er zijn wat 
tranen vergoten, maar we konden elkaar altijd steunen. Vooral is er eigenlijk erg veel en erg hard 
gelachen! Zonder jullie was de tijd in het Westeinde niet hetzelfde geweest. Ook de collega’s in 
het UMCG draag ik een warm hart toe. Na mijn wissel ben ik hartelijk ontvangen en ik voelde 
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mij daardoor snel thuis. Dank aan de collega’s op de onderzoekskamer, maar natuurlijk ook op 
de werkvloer. 
Als laatste wil ik vrienden en familie bedanken. Alle gezellige avonden en praten over grote en 
kleine dingen zijn o zo belangrijk geweest. Mijn lieve vriendinnen en hun mannen die al vrienden 
waren of na al die jaren ook vrienden zijn geworden. Allereerst mijn paranimfen: Noortje en Ellen.
Noortje; sinds we samen op een tandem stapten in 2002 hebben we veel meegemaakt. Je staat 
altijd voor je vriendinnen klaar, met warmte, advies en een lekker hapje. 
Ellen; wij hebben samen vooral niet zo hard geroeid, maar wel veel leuke dingen gedeeld. Mooie 
reizen en een hele tijd een nogal rommelig huis. Leuk dat we nu weer zo dichtbij wonen!
Kim, en Marloes; laten we altijd een beetje hertjes blijven. Jitske, Meike en Willemijn; dank voor 
de momenten van kostbare ontspanning . Edith en Martijn, tot de volgende logeerpartij. Vrien-
delijk heid, een luisterend oor en balans is bij jullie het motto.
Pap en mam, jullie hebben me altijd in de goede richting geholpen. Jullie hebben me mijn eigen 
weg laten vinden, vriendelijk en vol vertrouwen. Dit door me niet te laten stoppen met schei-
kunde, allerlei teksten mee te lezen, het DPI gehalte van illustraties op te peppen, of op de 
kinderen te passen. Je kan het niet bedenken of ik kon het vragen. Dank voor alles! Ome Louis, 
hopelijk kom je nog vaker op bezoek bij ons en de meisjes. 
Oma Gerrie, zonder jou en Koos was Robert niet de lieve steun geweest die hij is. Dank voor 
jullie warmte.
Benthe, Elke en Linde, ik ben ongelofelijk blij met jullie. Jullie zijn de liefsten!
Lieve Robert, zonder jou was ik nergens. Je steunt me en remt me waar nodig, je laat me 
groeien. Samen redden we het wel. Mocht je naar aanleiding hiervan een vraag hebben, ik hoor 
hem graag.
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Imanda Maria Elisabeth (Manda) werd op 21 januari 1983 geboren in Amsterdam. In 2001 behaal-
de zij haar VWO diploma aan het Vossius Gymnasium te Amsterdam en dat jaar begon zij haar 
geneeskunde studie aan de Rijksuniversiteit in Groningen. In 2004 deed zij een internationale 
stage neurologie in Finland, waar haar interesse in het vak werd gewekt. Zij volgde twee semi-
arts stages neurologie; in het Academisch Medisch Centrum in Amsterdam en tevens in het 
Haaglanden MC te den Haag.
Na het behalen van haar Geneeskunde diploma in 2009 werkte zij als ANIOS neurologie in 
het Kennemergasthuis in Haarlem. In mei 2010 begon zij haar opleiding tot neuroloog in het 
Haaglanden MC Met als opleider dr. Vecht en later prof. Taphoorn.
Door gezinsuitbreiding en werk van haar man in Groningen heeft Manda de laatste 2 jaar van 
haar opleiding in het Universitair Medisch Centrum Groningen afgerond. In deze periode deed 
zij een differentiatie stage bewegingsstoornissen onder begeleiding van prof. M.A.J. de Koning-
Tijssen en prof. T. van Laar. Het zwaartepunt van de stage lag bij de ziekte van Parkinson. 
Aanvullend deed zij een tweede differentiatie stage bij de geriatrie onder begeleiding van dr. 
D.Z.B. van Asselt. Aandachtsgebied tijdens deze stage was cognitieve stoornissen en zorg voor 
de oudere patient met multiproblematiek. 
Gedurende haar opleiding heeft Manda naast het onderzoek voor het voltooien van haar proef-
schrift deelgenomen aan de studie  “Corticosteroid injection in patients with ulnar neuropathy 
at the elbow: A. randomized, double-blind, placebo-controlled trial” en gepubliceerd in Muscle 
Nerve in 2014. 
Sinds juli 2016 is Manda werkzaam als neuroloog in het Meander MC te Amerfoort met als aan-
dachtsgebied de ziekte van Parkinson en cognitieve stoornissen. Zij woont samen met Robert 
Nijborg in Soest en heeft drie dochters; Benthe, Elke en Linde.
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